JPS6244221B2 - - Google Patents
Info
- Publication number
- JPS6244221B2 JPS6244221B2 JP51096157A JP9615776A JPS6244221B2 JP S6244221 B2 JPS6244221 B2 JP S6244221B2 JP 51096157 A JP51096157 A JP 51096157A JP 9615776 A JP9615776 A JP 9615776A JP S6244221 B2 JPS6244221 B2 JP S6244221B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- layer
- red blood
- antibody
- blood cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004027 cell Anatomy 0.000 claims description 122
- 239000010410 layer Substances 0.000 claims description 93
- 210000003743 erythrocyte Anatomy 0.000 claims description 79
- 238000000034 method Methods 0.000 claims description 69
- 239000000427 antigen Substances 0.000 claims description 62
- 102000036639 antigens Human genes 0.000 claims description 61
- 108091007433 antigens Proteins 0.000 claims description 61
- 239000002356 single layer Substances 0.000 claims description 58
- 239000000243 solution Substances 0.000 claims description 54
- 239000000758 substrate Substances 0.000 claims description 53
- 239000007787 solid Substances 0.000 claims description 33
- 239000000725 suspension Substances 0.000 claims description 31
- 230000000295 complement effect Effects 0.000 claims description 30
- 210000002966 serum Anatomy 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 230000027455 binding Effects 0.000 claims description 19
- 238000004458 analytical method Methods 0.000 claims description 13
- 230000000890 antigenic effect Effects 0.000 claims description 13
- 229940012952 fibrinogen Drugs 0.000 claims description 10
- 102000008946 Fibrinogen Human genes 0.000 claims description 9
- 108010049003 Fibrinogen Proteins 0.000 claims description 9
- 239000004793 Polystyrene Substances 0.000 claims description 9
- 229920002223 polystyrene Polymers 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 108060003951 Immunoglobulin Proteins 0.000 claims description 7
- 108010039918 Polylysine Proteins 0.000 claims description 7
- 102000018358 immunoglobulin Human genes 0.000 claims description 7
- 229920000656 polylysine Polymers 0.000 claims description 7
- 230000001464 adherent effect Effects 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 102000007327 Protamines Human genes 0.000 claims description 3
- 108010007568 Protamines Proteins 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 229950008679 protamine sulfate Drugs 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 230000001629 suppression Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 125000003636 chemical group Chemical group 0.000 claims 8
- 239000002344 surface layer Substances 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 230000002391 anti-complement effect Effects 0.000 claims 2
- 108010008730 anticomplement Proteins 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 230000009257 reactivity Effects 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 75
- 210000000601 blood cell Anatomy 0.000 description 58
- 210000004369 blood Anatomy 0.000 description 26
- 239000008280 blood Substances 0.000 description 26
- 230000004520 agglutination Effects 0.000 description 23
- 239000007790 solid phase Substances 0.000 description 17
- 239000007791 liquid phase Substances 0.000 description 14
- 230000002776 aggregation Effects 0.000 description 9
- 238000004220 aggregation Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000009582 blood typing Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 239000013553 cell monolayer Substances 0.000 description 5
- 230000002860 competitive effect Effects 0.000 description 5
- 238000000326 densiometry Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 210000001772 blood platelet Anatomy 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000035931 haemagglutination Effects 0.000 description 4
- 230000008105 immune reaction Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000910 agglutinin Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 101710186708 Agglutinin Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 101710146024 Horcolin Proteins 0.000 description 2
- 101710189395 Lectin Proteins 0.000 description 2
- 101710179758 Mannose-specific lectin Proteins 0.000 description 2
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 2
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000009137 competitive binding Effects 0.000 description 2
- 230000006957 competitive inhibition Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000007475 hemolytic anemia Diseases 0.000 description 2
- 230000016178 immune complex formation Effects 0.000 description 2
- 229940088592 immunologic factor Drugs 0.000 description 2
- 239000000367 immunologic factor Substances 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000011158 quantitative evaluation Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- MEXAGTSTSPYCEP-NUBCRITNSA-N (2r)-2,6-diaminohexanoic acid;hydrobromide Polymers Br.NCCCC[C@@H](N)C(O)=O MEXAGTSTSPYCEP-NUBCRITNSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101710088235 Envelope glycoprotein C homolog Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100038567 Properdin Human genes 0.000 description 1
- 108010005642 Properdin Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- -1 antibodies Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical group BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Description
ãçºæã®è©³çŽ°ãªèª¬æã
åéåå¿ãŸãã¯å
ç«åŽ©å£ã®äœããã«åºã¥ãåºçž
è¡æ¶²åå€å®æ¹æ³ãç¥ãããŠãããæ¬çºæã«ãããŠ
ã¯ã现èã®åäžå±€ãéå¯éçã«ïŒããšãã°å ±æçµ
åçã«ïŒãåºäœåºè³ªïŒmatrixïŒã«çµåãããç¶ã
ã®ã¡ãæäœãå«æããè¡æž ããçµåãã现èå±€ãš
æ¥è§Šããããçµåãã现èã«ããæäœã®å ç«åžç
ã¯ã现èèã®æåãšè¡æž äžã®æäœãçžäºã«è£è¶³æ§
ã§ããå Žåã«çããããã®æäœæäœããè¡çã®å
äžå±€ã¯ãè£è¶³æ§æåãæããè¡çã®ç¬¬äºã®å±€ãçµ
åããïŒåºçžåéåå¿ïŒãããããã¯è¡æž è£äœã®
ååšã«ãããŠåŽ©å£ãããïŒåºçžå ç«æ§åŽ©å£ïŒã®äœ
ãããåããããšãã§ãããåºäœåºè³ªã«çµåãã
è¡çã®åäžå±€ïŒmonoâlayerïŒã«ãããããã®å
å¿ã®éè¡ã¯ãæ¿åºŠèšã«ããèµ°æ»ãæŸå°æ§åäœå çŽ
ã®èšæ°ã®ãããªæšæºçãªæ©åšãçšããæ¹æ³ã«ã
ããçµæã®å®éçãªè©äŸ¡ãå¯èœãšããã
è¡æ¶²åå€å®æ¹æ³ãç¥ãããŠãããæ¬çºæã«ãããŠ
ã¯ã现èã®åäžå±€ãéå¯éçã«ïŒããšãã°å ±æçµ
åçã«ïŒãåºäœåºè³ªïŒmatrixïŒã«çµåãããç¶ã
ã®ã¡ãæäœãå«æããè¡æž ããçµåãã现èå±€ãš
æ¥è§Šããããçµåãã现èã«ããæäœã®å ç«åžç
ã¯ã现èèã®æåãšè¡æž äžã®æäœãçžäºã«è£è¶³æ§
ã§ããå Žåã«çããããã®æäœæäœããè¡çã®å
äžå±€ã¯ãè£è¶³æ§æåãæããè¡çã®ç¬¬äºã®å±€ãçµ
åããïŒåºçžåéåå¿ïŒãããããã¯è¡æž è£äœã®
ååšã«ãããŠåŽ©å£ãããïŒåºçžå ç«æ§åŽ©å£ïŒã®äœ
ãããåããããšãã§ãããåºäœåºè³ªã«çµåãã
è¡çã®åäžå±€ïŒmonoâlayerïŒã«ãããããã®å
å¿ã®éè¡ã¯ãæ¿åºŠèšã«ããèµ°æ»ãæŸå°æ§åäœå çŽ
ã®èšæ°ã®ãããªæšæºçãªæ©åšãçšããæ¹æ³ã«ã
ããçµæã®å®éçãªè©äŸ¡ãå¯èœãšããã
å€ãã®å»çéçšã«ãããŠãäŸè¡è
ãšæ£è
ã®éã®
茞è¡åãŸãã¯ç§»æ€åã®è¡çé©åæ§ã®å€å®ãå¿ èŠãš
ãããè¡çé©åæ§ã¯ãæ£è ã®è¡æž äžã«å«ãŸããæ
äœãšäŸè¡è ããã®è¡çäžã«ååšããæåã®éã«å
ç«åŠçåå¿ãçããªãããšã«ãã€ãŠç¢ºãããã
ããããšãã°ãæ£è ã®èµ€è¡çãåïŒããªãã¡ã
èµ€è¡çäžã«ââæåãæããïŒã§ããå Žåã¯ã
ãã®ãããªæ£è ã®è¡æ¶²ã®è¡æž ã¯ãæâæäœãã
ãªãã¡ãââè¡çãšåå¿ããæäœããæããŠã
ãããããæ£è ãââåã®è¡æ¶²ã®äŸäžãåãã
ãšãã¯ãæ£è ã®è¡æž ã®æâæäœãšäŸè¡è ã®èµ€è¡
çã®ïŒ¢âæåã®éã«å ç«åŠçåå¿ãçããããã®
ãããªäžé©åã¯è管å 溶è¡åå¿ã®ããã«ãé倧ãª
çµæãããããããããããã
茞è¡åãŸãã¯ç§»æ€åã®è¡çé©åæ§ã®å€å®ãå¿ èŠãš
ãããè¡çé©åæ§ã¯ãæ£è ã®è¡æž äžã«å«ãŸããæ
äœãšäŸè¡è ããã®è¡çäžã«ååšããæåã®éã«å
ç«åŠçåå¿ãçããªãããšã«ãã€ãŠç¢ºãããã
ããããšãã°ãæ£è ã®èµ€è¡çãåïŒããªãã¡ã
èµ€è¡çäžã«ââæåãæããïŒã§ããå Žåã¯ã
ãã®ãããªæ£è ã®è¡æ¶²ã®è¡æž ã¯ãæâæäœãã
ãªãã¡ãââè¡çãšåå¿ããæäœããæããŠã
ãããããæ£è ãââåã®è¡æ¶²ã®äŸäžãåãã
ãšãã¯ãæ£è ã®è¡æž ã®æâæäœãšäŸè¡è ã®èµ€è¡
çã®ïŒ¢âæåã®éã«å ç«åŠçåå¿ãçããããã®
ãããªäžé©åã¯è管å 溶è¡åå¿ã®ããã«ãé倧ãª
çµæãããããããããããã
è¡æ¶²åã®å€å®ããã³è¡æ¶²é©åæ§ã®è©Šéšã«ã¯ãäž
è¬ã«æ¬¡ã®ïŒçš®é¡ãããïŒ(i)è¡çã«å ããç¹å®ã®æ
äœãåéåå¿ãçãããã©ããã調ã¹ãæ€æ»ãã
ãã³(ii)è©Šéšè¡çã«å ããç¹å®ã®æäœãè¡æž è£äœãš
å ±ã«è¡çã®åŽ©å£ãçãããããã©ããã調ã¹ãæ€
æ»ã
è¬ã«æ¬¡ã®ïŒçš®é¡ãããïŒ(i)è¡çã«å ããç¹å®ã®æ
äœãåéåå¿ãçãããã©ããã調ã¹ãæ€æ»ãã
ãã³(ii)è©Šéšè¡çã«å ããç¹å®ã®æäœãè¡æž è£äœãš
å ±ã«è¡çã®åŽ©å£ãçãããããã©ããã調ã¹ãæ€
æ»ã
ãããã®äºã€ã®åºæ¬çãªè©Šéšã®ç¬¬äžã®ãã®ãå
éåå¿ã¯ãè£äœã®ååšãªãã§æâæäœãå ã
ããäŸãã°ãåæåå«æè¡çã®åéã«é¢ããã
ã®ã§ãããâæåããã³æâæäœã¯ãé£æ¥ã
ãè¡çéã«æ©ã圢æããæäœã«ããå ç«åŠçåå¿
ã«ãã€ãŠçžäºã«ç¹å®çã«åå¿ãããããã«ãã€
ãŠãæ·»å ããæäœã«ããçžäºã«çµåããè¡çã®æ±
åäœãçããã
éåå¿ã¯ãè£äœã®ååšãªãã§æâæäœãå ã
ããäŸãã°ãåæåå«æè¡çã®åéã«é¢ããã
ã®ã§ãããâæåããã³æâæäœã¯ãé£æ¥ã
ãè¡çéã«æ©ã圢æããæäœã«ããå ç«åŠçåå¿
ã«ãã€ãŠçžäºã«ç¹å®çã«åå¿ãããããã«ãã€
ãŠãæ·»å ããæäœã«ããçžäºã«çµåããè¡çã®æ±
åäœãçããã
äžèšã®äž¡è©Šéšã®äžã®ç¬¬äºã®ãã®ãè¡ç厩å£ã
ã¯ãè¡çã®æ»æ» ããã³è¡çå 容ç©ã®æŸåºãã¿ã¡ã³
ãè¡çèã®ç Žå£ã«é¢ãããã®ã§ãããâè¡ç厩
å£âã¯ãæ£åžžãªè¡æž äžã®æœåšçã«ç Žå£çãªèçœè³ª
矀ïŒâè£äœâãšåŒã°ããïŒãšè¡çèã«çµåããæ
äœãšã®éã«çããåå¿ã®çµæã§ããã
ã¯ãè¡çã®æ»æ» ããã³è¡çå 容ç©ã®æŸåºãã¿ã¡ã³
ãè¡çèã®ç Žå£ã«é¢ãããã®ã§ãããâè¡ç厩
å£âã¯ãæ£åžžãªè¡æž äžã®æœåšçã«ç Žå£çãªèçœè³ª
矀ïŒâè£äœâãšåŒã°ããïŒãšè¡çèã«çµåããæ
äœãšã®éã«çããåå¿ã®çµæã§ããã
äžèšã®äž¡æ¹æ³ã¯å
±ã«ã现èç¶ã®è¡æ¶²èŠçŽ ãããª
ãã¡ãèµ€è¡çãé¡ç²çããªã³ãçããã³è¡å°æ¿
ïŒæ çïŒãã®åã®å€å®ããã³äžé©åæ€æ»ã«å¯ŸããŠçš
ããããããã°ãã°å®æ§çã«ã®ã¿äœ¿çšããããã
ã©ããäž¡æ¹æ³ã¯å ±ã«ãæ¬è³ªçã«å®éåå¯èœã§ãã€
ãŠããããããæåãæäœããã³è¡æž è£äœã®è©äŸ¡
åæã«å¯ŸããŠçšããããŠããã
ãã¡ãèµ€è¡çãé¡ç²çããªã³ãçããã³è¡å°æ¿
ïŒæ çïŒãã®åã®å€å®ããã³äžé©åæ€æ»ã«å¯ŸããŠçš
ããããããã°ãã°å®æ§çã«ã®ã¿äœ¿çšããããã
ã©ããäž¡æ¹æ³ã¯å ±ã«ãæ¬è³ªçã«å®éåå¯èœã§ãã€
ãŠããããããæåãæäœããã³è¡æž è£äœã®è©äŸ¡
åæã«å¯ŸããŠçšããããŠããã
ä»æ¥ãå»çã®åéã«ãããŠåžžçšãããè¡çåã®
å€å®ããã³é©åæ§ã®è©Šéšæ¹æ³ã«ãããŠã¯ãåéè©Š
éšããã³è¡ç厩å£è©Šéšã®äœããã液çžäžã§è¡ãªã
ãããããªãã¡ãè©Šéšãã¹ãè£äœã®ååšãŸãã¯äž
åšäžã«ãæäœãå«æããè¡æž ããè¡æ¶²åã®å€å®ãŸ
ãã¯é©åæ§ã®è©Šéšã®å¯Ÿè±¡ãšãã¹ãè¡çã®æžæ¿æ¶²ãš
æ··åãããéåžžã¯äžå®ã®éã䜿çšããã
å€å®ããã³é©åæ§ã®è©Šéšæ¹æ³ã«ãããŠã¯ãåéè©Š
éšããã³è¡ç厩å£è©Šéšã®äœããã液çžäžã§è¡ãªã
ãããããªãã¡ãè©Šéšãã¹ãè£äœã®ååšãŸãã¯äž
åšäžã«ãæäœãå«æããè¡æž ããè¡æ¶²åã®å€å®ãŸ
ãã¯é©åæ§ã®è©Šéšã®å¯Ÿè±¡ãšãã¹ãè¡çã®æžæ¿æ¶²ãš
æ··åãããéåžžã¯äžå®ã®éã䜿çšããã
åéè©Šéšçµæã®å€å®ã¯ãæè¡è
ããç¹ç°çãªæ
åâæäœååçæ¶æ©ã«ãã现èã®åéãšãé¢ä¿ã®
ãªãäœçšããã¯ãããçšåºŠã®åéãçããããé
ç¹ç°çãªçŽ°èã®åéãšããèå¥ããããšãå¿ èŠãš
ãããæè¡è ã¯ãååšããå¯èœæ§ã®ããéé¢ã®å
éããŠããªã现èããåéããŠãã现èããåºå¥
ããããšããŸããã§ããªããã°ãªããªããããã¯
é«åºŠã«çç·Žããæè¡è ãŸãã¯é«äŸ¡ãªè£ 眮ã«ããã
粟確ãªç²ååã®å€å®ããã³èšæ°ãå¿ èŠãšãããå
ããã«ãç¹å®çãªåéã®çšåºŠã®æž¬å®ã¯ã貧匱ãªå
å®éçãªãã®ã§ãããããŸãã¯éè¡ããããã«è²»
çšããããäžã€ãã€ãããªãã®ã§ãããã©ã¡ãã
ã§ããã
åâæäœååçæ¶æ©ã«ãã现èã®åéãšãé¢ä¿ã®
ãªãäœçšããã¯ãããçšåºŠã®åéãçããããé
ç¹ç°çãªçŽ°èã®åéãšããèå¥ããããšãå¿ èŠãš
ãããæè¡è ã¯ãååšããå¯èœæ§ã®ããéé¢ã®å
éããŠããªã现èããåéããŠãã现èããåºå¥
ããããšããŸããã§ããªããã°ãªããªããããã¯
é«åºŠã«çç·Žããæè¡è ãŸãã¯é«äŸ¡ãªè£ 眮ã«ããã
粟確ãªç²ååã®å€å®ããã³èšæ°ãå¿ èŠãšãããå
ããã«ãç¹å®çãªåéã®çšåºŠã®æž¬å®ã¯ã貧匱ãªå
å®éçãªãã®ã§ãããããŸãã¯éè¡ããããã«è²»
çšããããäžã€ãã€ãããªãã®ã§ãããã©ã¡ãã
ã§ããã
åéåå¿ã«ããèµ€è¡çã®åã®å€å®ã®ããã®ãã
ã€ãã®è©ŠéšãéçºãããŠããããã©ãããããã®
æ¹æ³ã®ããã®è£ 眮ã¯ã䜿çšããããšãè²»çšãèŠã
ããšå ±ã«ãã€ããã§ãããããšãã°ãæ©åšã«ãã
èµ€è¡çã®åã®å€å®ã®ããã«ææ¡ãããŠããäžè£ 眮
ã¯ããã«ã¯ãã³ãã«ãããTransfusionã第11
å·»ã第ïŒå·ã317é 以äžïŒ1971ïŒã«èšãããŠãã
âãªãŒãã¢ãã©ã€ã¶ãŒâïŒAutoanalyzerïŒãšããŠ
ç¥ãããŠããããªãŒãã¢ãã©ã€ã¶ãŒã«ãããŠã¯ã
è¡æ¶²è©Šæããã³æäœè¡æž ããåéãçããããã
ãã«èšèšããè€éãªç®¡ç¶ã®è管äžã§ç¹å¥ãªç°å¢äž
ã«æ··åããã次ãã§åå¿è管ããçæããåéç©
ãé€å»ããããããããªäžåãã®äœçœ®ã«ããèã
æããââçµå管ã«éãããéåéåºåãéã¶
ââå管ããã®æµåºæ¶²ã®å åŠå¯åºŠã®äœäžã枬å®
ããããšã«ããïŒãã«ã¯ãã³ãïŒããŸãââ管
ããã®åéç©ãçŽäžã«ãã©ããããããšã«ãã€
ãŠïŒã·ãŒã«ãããTransfusionã第ïŒå·»ã348
é ã1969幎ïŒãåéãæ€åºããããšãã§ãããã
ãããªããããã®è£ 眮ã¯è€éäžã€é«äŸ¡ã§ãããè¡
液ã貯èµãã蚺çæã«ãããæ¥åžžã®äœ¿çšã«å¯ŸããŠ
é©ããç°¡åãªèªååæ¹æ³ã«ã¯åœ¹ç«ããªãã
ã€ãã®è©ŠéšãéçºãããŠããããã©ãããããã®
æ¹æ³ã®ããã®è£ 眮ã¯ã䜿çšããããšãè²»çšãèŠã
ããšå ±ã«ãã€ããã§ãããããšãã°ãæ©åšã«ãã
èµ€è¡çã®åã®å€å®ã®ããã«ææ¡ãããŠããäžè£ 眮
ã¯ããã«ã¯ãã³ãã«ãããTransfusionã第11
å·»ã第ïŒå·ã317é 以äžïŒ1971ïŒã«èšãããŠãã
âãªãŒãã¢ãã©ã€ã¶ãŒâïŒAutoanalyzerïŒãšããŠ
ç¥ãããŠããããªãŒãã¢ãã©ã€ã¶ãŒã«ãããŠã¯ã
è¡æ¶²è©Šæããã³æäœè¡æž ããåéãçããããã
ãã«èšèšããè€éãªç®¡ç¶ã®è管äžã§ç¹å¥ãªç°å¢äž
ã«æ··åããã次ãã§åå¿è管ããçæããåéç©
ãé€å»ããããããããªäžåãã®äœçœ®ã«ããèã
æããââçµå管ã«éãããéåéåºåãéã¶
ââå管ããã®æµåºæ¶²ã®å åŠå¯åºŠã®äœäžã枬å®
ããããšã«ããïŒãã«ã¯ãã³ãïŒããŸãââ管
ããã®åéç©ãçŽäžã«ãã©ããããããšã«ãã€
ãŠïŒã·ãŒã«ãããTransfusionã第ïŒå·»ã348
é ã1969幎ïŒãåéãæ€åºããããšãã§ãããã
ãããªããããã®è£ 眮ã¯è€éäžã€é«äŸ¡ã§ãããè¡
液ã貯èµãã蚺çæã«ãããæ¥åžžã®äœ¿çšã«å¯ŸããŠ
é©ããç°¡åãªèªååæ¹æ³ã«ã¯åœ¹ç«ããªãã
ããäžã€ã®è£
眮ã¯ãâã°ã«ãŒããããã¯â
ïŒGroupamticïŒãšããŠå ¬ç¥ã§ãããæ°åäžãã«ã®
äŸ¡æ Œãæãããã®ã§ããïŒGarrettaããVox
Sang.第27å·»ã141é ã1974幎åç §ïŒãã°ã«ãŒãã
ããã¯è£ 眮ã«ãããŠã¯ãè¡æž ããã³è¡çæžæ¿æ¶²ã
æ··åããŠãåéãçãããããåéã®ååšã¯æžæ¿
液ã暪åã€ãŠïŒæ¬ã®å ç·ãééãããããšã«ãã€
ãŠæ€åºãããããã®äžã®äžæ¬ã¯åå¿ã»ã«ã®äžå¿ã
ééããäžæ¹ãä»ã®å ã¯åšèŸºãééãããå ç·ã®
ééçã®å·®ãåéã®åŒ·ãã®å°ºåºŠãšããŠæ±ãããã
ãããªãããè€éãªåè·¯ãå¿ èŠã§ãã€ãŠãæ倧ã®
è¡æ¶²éè¡ãé€ããŠã¯ããã®è£ 眮ãè³éé¢ã§å°åºæ
ã®å±ããªããã®ãšããŠããã
ïŒGroupamticïŒãšããŠå ¬ç¥ã§ãããæ°åäžãã«ã®
äŸ¡æ Œãæãããã®ã§ããïŒGarrettaããVox
Sang.第27å·»ã141é ã1974幎åç §ïŒãã°ã«ãŒãã
ããã¯è£ 眮ã«ãããŠã¯ãè¡æž ããã³è¡çæžæ¿æ¶²ã
æ··åããŠãåéãçãããããåéã®ååšã¯æžæ¿
液ã暪åã€ãŠïŒæ¬ã®å ç·ãééãããããšã«ãã€
ãŠæ€åºãããããã®äžã®äžæ¬ã¯åå¿ã»ã«ã®äžå¿ã
ééããäžæ¹ãä»ã®å ã¯åšèŸºãééãããå ç·ã®
ééçã®å·®ãåéã®åŒ·ãã®å°ºåºŠãšããŠæ±ãããã
ãããªãããè€éãªåè·¯ãå¿ èŠã§ãã€ãŠãæ倧ã®
è¡æ¶²éè¡ãé€ããŠã¯ããã®è£ 眮ãè³éé¢ã§å°åºæ
ã®å±ããªããã®ãšããŠããã
å
ç«åŽ©å£ã«åºã¥ãè©Šéšã¯ã现èè¡šé¢ã®æåâæ
äœåå¿ããçµç¹ïŒããšãã°HLâïŒåã®å€å®ã®
å Žåãšåæ§ã«ãè£äœãšå¹ççã«äœçšããå Žåã«
ã¯ãäœã®åé¡ãååšããªããæ®å¿µãªãããè¡çè
æåâæäœè€åäœãè£äœãšæå¹ã«äœçšããªããã
ãŸãã¯å ç«åŽ©å£ãæ©æ¢°çã«åŠšå®³ããé«åºŠã®åéã
é²ãããã«æäœæ¿åºŠãéå®ããªããã°ãªããªã
ããã©ã¡ããã®ã人éã®èµ€è¡çã®å Žåã«ãããŠ
ã¯ãäžèšã®ãããªããšã¯ãã€ãã«ãªãã
äœåå¿ããçµç¹ïŒããšãã°HLâïŒåã®å€å®ã®
å Žåãšåæ§ã«ãè£äœãšå¹ççã«äœçšããå Žåã«
ã¯ãäœã®åé¡ãååšããªããæ®å¿µãªãããè¡çè
æåâæäœè€åäœãè£äœãšæå¹ã«äœçšããªããã
ãŸãã¯å ç«åŽ©å£ãæ©æ¢°çã«åŠšå®³ããé«åºŠã®åéã
é²ãããã«æäœæ¿åºŠãéå®ããªããã°ãªããªã
ããã©ã¡ããã®ã人éã®èµ€è¡çã®å Žåã«ãããŠ
ã¯ãäžèšã®ãããªããšã¯ãã€ãã«ãªãã
ãããã®åé¡ã¯ãæ¥åžžã®èµ€è¡çåå€å®ãããçž
å€ãããçç·Žããçµéšè ãèŠæ±ãããæéã®ãã
ãã人æã«ããäœæ¥ã«ããã€ãŠããè¡æ¶²éè¡è¡æž
åŠè©Šéšå®€ã®äœæ¥ã«å€§ããªåœ±é¿ãäžããããã®äžã
æ¯èŒçå ããªè¡æ¶²éè¡ããçµç¹åã®æ€åºã®ããã«
å¿ èŠãªãªã³ãçæ¯æ§è©Šéšãè¡ãªãããšãã§ããã«
ãããªããé¡ç²çã®èŒžè¡åé©åæ§ãå€å®ãããã
ã«çšãããçŽæ¥çãªå ç«åŠçè©Šéšã¯ååšããããŸ
ãè¡å°æ¿ã«å¯ŸããŠã¯ãããšãã°14Cã»ãããã³è§£
æŸã®ãããªãéæ¥çãªè©Šéšãååšããã«ãããª
ããïŒé¡ç²çããã³è¡å°æ¿ã¯ãéžæããé©åœãªè©Š
éšã«ãã€ãŠHLâåãåž°å±ããããšãã§ãã
ãããããå€å®ã¯ããããã®é©åæ§ãä¿èšŒããã
ã®ã§ã¯ãªãïŒã
å€ãããçç·Žããçµéšè ãèŠæ±ãããæéã®ãã
ãã人æã«ããäœæ¥ã«ããã€ãŠããè¡æ¶²éè¡è¡æž
åŠè©Šéšå®€ã®äœæ¥ã«å€§ããªåœ±é¿ãäžããããã®äžã
æ¯èŒçå ããªè¡æ¶²éè¡ããçµç¹åã®æ€åºã®ããã«
å¿ èŠãªãªã³ãçæ¯æ§è©Šéšãè¡ãªãããšãã§ããã«
ãããªããé¡ç²çã®èŒžè¡åé©åæ§ãå€å®ãããã
ã«çšãããçŽæ¥çãªå ç«åŠçè©Šéšã¯ååšããããŸ
ãè¡å°æ¿ã«å¯ŸããŠã¯ãããšãã°14Cã»ãããã³è§£
æŸã®ãããªãéæ¥çãªè©Šéšãååšããã«ãããª
ããïŒé¡ç²çããã³è¡å°æ¿ã¯ãéžæããé©åœãªè©Š
éšã«ãã€ãŠHLâåãåž°å±ããããšãã§ãã
ãããããå€å®ã¯ããããã®é©åæ§ãä¿èšŒããã
ã®ã§ã¯ãªãïŒã
åºãæ¬çºæã®ç¯å²å
ã«ãããŠãããããã¯ãå
å¿æ§ã®è¡çã®åäžå±€ãäžå¯éçã«åºäœåºè³ªã«å¯Ÿã
ãŠçµåãããããªãã°ã人éã®è¡çã«å¯Ÿããåé
åå¿ããã³è¡ç厩å£è©Šéšã®äž¡æ¹æ³ããèããæ¹è¯
ããããšãã§ãããšããããšãèŠåºãããç¶ãã®
ã¡ããã®å±€ãè¡çå±€ã«å¯Ÿããå ç«åžçã«ããåå¿
ããèœåã®ããæäœãå«æãã溶液ïŒããªãã¡è¡
æž ïŒãšæ¥è§Šãããäžã€å ç«åžçãçããçšåºŠã枬
å®ããããããããéçºããåºæ¬åçãçšããã
ãäžã€ã®æ¹æ³ã«ãããŠã¯ã现èæ¯éå£äžã®çŽ°èè¡š
é¢äžã«ååšããå ç«åŠçèŠå ïŒããªãã¡æäœãŸã
ã¯æåïŒã®ååšãïŒ (a) è©Šéšãã¹ã现èæ¯éå£äžã®çŽ°èã®ç¬¬äžã®æžæ¿
液ããããã现èã®åäžå±€ãåºè³ªã«å¯ŸããŠäžå¯
éçã«çµåãããããã«æå¹ãªæ¡ä»¶äžã«ãåºäœ
åºè³ªã«å¯ŸããŠäœçšããïŒ (b) ããã«ãã€ãŠçæãã现èå±€ãå ¬ç¥ã®ç¹ç°æ§
ã®æäœãŸãã¯æåãå«æãã液äœïŒãŸãã¯è¡
æž ïŒãšæ¥è§ŠããïŒäžã€ (c) ç¶ãã®ã¡çŽ°èå±€äžãžã®æåãŸãã¯æäœã®å ç«
åžçã®çšåºŠã枬å®ããã ããšã«ãã€ãŠè©äŸ¡åæããããšãã§ããã
å¿æ§ã®è¡çã®åäžå±€ãäžå¯éçã«åºäœåºè³ªã«å¯Ÿã
ãŠçµåãããããªãã°ã人éã®è¡çã«å¯Ÿããåé
åå¿ããã³è¡ç厩å£è©Šéšã®äž¡æ¹æ³ããèããæ¹è¯
ããããšãã§ãããšããããšãèŠåºãããç¶ãã®
ã¡ããã®å±€ãè¡çå±€ã«å¯Ÿããå ç«åžçã«ããåå¿
ããèœåã®ããæäœãå«æãã溶液ïŒããªãã¡è¡
æž ïŒãšæ¥è§Šãããäžã€å ç«åžçãçããçšåºŠã枬
å®ããããããããéçºããåºæ¬åçãçšããã
ãäžã€ã®æ¹æ³ã«ãããŠã¯ã现èæ¯éå£äžã®çŽ°èè¡š
é¢äžã«ååšããå ç«åŠçèŠå ïŒããªãã¡æäœãŸã
ã¯æåïŒã®ååšãïŒ (a) è©Šéšãã¹ã现èæ¯éå£äžã®çŽ°èã®ç¬¬äžã®æžæ¿
液ããããã现èã®åäžå±€ãåºè³ªã«å¯ŸããŠäžå¯
éçã«çµåãããããã«æå¹ãªæ¡ä»¶äžã«ãåºäœ
åºè³ªã«å¯ŸããŠäœçšããïŒ (b) ããã«ãã€ãŠçæãã现èå±€ãå ¬ç¥ã®ç¹ç°æ§
ã®æäœãŸãã¯æåãå«æãã液äœïŒãŸãã¯è¡
æž ïŒãšæ¥è§ŠããïŒäžã€ (c) ç¶ãã®ã¡çŽ°èå±€äžãžã®æåãŸãã¯æäœã®å ç«
åžçã®çšåºŠã枬å®ããã ããšã«ãã€ãŠè©äŸ¡åæããããšãã§ããã
åºäœåºè³ªãžã®çŽ°èã®éå¯éççµåãšã¯ã现èè¡š
é¢äžã®ç¹ãšåºè³ªäžã®åå¿æ§åºãšã®éã®ååŠçå ±æ
çµåã®çæã®ãããªãååéåã«ããåå¿ãã现
èã®çµåããããã¯ãããšãã°ãã¢ã³ãã«ã¯ãŒã«
ã¹åãã¯ãŒãã³åãŸãã¯æ°ŽçŽ çµåã®ããã«æ¯èŒç
匱ãã以åŸã®æé ã®æ¡ä»¶ã®åœ±é¿ã«ã¯èããããšã
ã§ããååéåã«ããçµåã®çæããããã®ã§ã
ããè©Šéšæ¹æ³ã®æ床ãå¢å€§ããã®ã¿ãªãããå ç«
åå¿ã®çµæããç°¡åãªèšè£ ã«ãã€ãŠå®¹æã«æž¬å®å¯
èœãšãªãã
é¢äžã®ç¹ãšåºè³ªäžã®åå¿æ§åºãšã®éã®ååŠçå ±æ
çµåã®çæã®ãããªãååéåã«ããåå¿ãã现
èã®çµåããããã¯ãããšãã°ãã¢ã³ãã«ã¯ãŒã«
ã¹åãã¯ãŒãã³åãŸãã¯æ°ŽçŽ çµåã®ããã«æ¯èŒç
匱ãã以åŸã®æé ã®æ¡ä»¶ã®åœ±é¿ã«ã¯èããããšã
ã§ããååéåã«ããçµåã®çæããããã®ã§ã
ããè©Šéšæ¹æ³ã®æ床ãå¢å€§ããã®ã¿ãªãããå ç«
åå¿ã®çµæããç°¡åãªèšè£ ã«ãã€ãŠå®¹æã«æž¬å®å¯
èœãšãªãã
ç°¡åãªäŸèšŒãšããŠãäžèšã®è¡æ¶²åå€å®è©Šéšãã
次ã®ïŒæ®µéã§éè¡ããããšãã§ããïŒ(1)èµ€è¡çã®
åäžå±€ïŒäžäŸãšããŠïŒ¡åã«ã€ããŠèª¬æããïŒãã
éå¯éçã«åºäœåºè³ªã«çµåãããïŒ(2)è¡çåäžå±€
ãå ç«çåžçå€ãšããŠäœ¿çšããŠãããšãã°æâ
æäœã®ãããªæäœãäœçšãããŠç¹ç°çã«åžçãã
ãããšãã§ããïŒããã³(3)æäœè¢«èŠããè¡çãã
次ãã§ãè£äœã«ããå ç«åŽ©å£ïŒåºäœåŽ©å£ïŒã«å¯Ÿã
ããããã®æåæ§ã«ã€ããŠããŸãã¯é©åœãªæåã
æããè¡çã®ç¬¬äºã®åäžå±€ãšçµåãã¹ããããã®
èœåïŒåºçžåéïŒã®äœãããè©Šéšããã°ããã
次ã®ïŒæ®µéã§éè¡ããããšãã§ããïŒ(1)èµ€è¡çã®
åäžå±€ïŒäžäŸãšããŠïŒ¡åã«ã€ããŠèª¬æããïŒãã
éå¯éçã«åºäœåºè³ªã«çµåãããïŒ(2)è¡çåäžå±€
ãå ç«çåžçå€ãšããŠäœ¿çšããŠãããšãã°æâ
æäœã®ãããªæäœãäœçšãããŠç¹ç°çã«åžçãã
ãããšãã§ããïŒããã³(3)æäœè¢«èŠããè¡çãã
次ãã§ãè£äœã«ããå ç«åŽ©å£ïŒåºäœåŽ©å£ïŒã«å¯Ÿã
ããããã®æåæ§ã«ã€ããŠããŸãã¯é©åœãªæåã
æããè¡çã®ç¬¬äºã®åäžå±€ãšçµåãã¹ããããã®
èœåïŒåºçžåéïŒã®äœãããè©Šéšããã°ããã
è©Šéšçµæã¯ãããšãã°ãé¡åŸ®é¡äžã®èŠ³å¯ã«ãã
ãšãããããªãäœããã®äŸ¿å®ã®æ¹æ³ã§è©äŸ¡ããã
ãšãã§ããïŒããããªãããæ¬çºæã«å¯ŸããŠç¹ã«
éèŠãªããšã¯ãè©Šéšçµæãæšæºçãªãäžã€å®¹æã«
å ¥æããããšãã§ããè£ çœ®ã䜿çšããæ¿åºŠæž¬å®ç
ãªæ¹æ³ã«ãã€ãŠè©äŸ¡ããããã«ãç¹ã«é©ããŠãã
ãšããããšã§ãããåºçžè¡çåéã«å¯ŸããŠã¯ãäž
èšã®ããã«ããŠèª¿è£œããè©Šéšãã¬ãŒãããè©Šéšã
ãèµ€è¡çã®ãã¢ã°ããã³å«éãåžå çã§ããæ³¢é·
ïŒããšãã°ã415nmã®æ³¢é·ãæããéè²å ãé©åœ
ã§ããïŒã«ãããŠéçãŸãã¯èµ°æ»ãã³ã·ãã¡ããª
ãŒã«ãããããšãã§ãããèµ°æ»ãã³ã·ãã¡ããªãŒ
ã¯ã容æã«å ¥æããããšãã§ãäžã€ãããšãã°(1)
第äºã®å±€ãçæããŠãããïŒ(2)ã©ã®äœã®æ°ã®è¡ç
ã第äºã®å±€ãæ§æããŠãããïŒããã³(3)第äºã®å±€
ã®ååžã¯ã©ã®ããã§ãããïŒïŒâååžâãšã¯ç¬¬äº
ã®å±€ã®åäžæ§ã«é¢ããããšã§ããïŒãšãããããª
åé¡ã«å¯Ÿããå®éçãªè§£çãäžããããšãã§ã
ããååã«ç¢ºç«ããè©Šéšè£ 眮ã®äœ¿çšãå å«ããã®
ã¿ã§ãããåäžãªç¬¬äºã®å±€ã¯ãäœçšãããæžæ¿æ¶²
äžã®è¡çã®100ïŒ ã第äžã®å±€ã«å¯ŸããŠçµåããã
ãã«å¿ èŠãªæåãä¿æããŠããããšãæå³ããã®
ã«å¯ŸããŠãäžåäžãªååžãšã¯ãäœçšãããæžæ¿æ¶²
äžã«ããçšåºŠã®âé°æ§âã®è¡çãååšããŠããã
ãšãæå³ããã
ãšãããããªãäœããã®äŸ¿å®ã®æ¹æ³ã§è©äŸ¡ããã
ãšãã§ããïŒããããªãããæ¬çºæã«å¯ŸããŠç¹ã«
éèŠãªããšã¯ãè©Šéšçµæãæšæºçãªãäžã€å®¹æã«
å ¥æããããšãã§ããè£ çœ®ã䜿çšããæ¿åºŠæž¬å®ç
ãªæ¹æ³ã«ãã€ãŠè©äŸ¡ããããã«ãç¹ã«é©ããŠãã
ãšããããšã§ãããåºçžè¡çåéã«å¯ŸããŠã¯ãäž
èšã®ããã«ããŠèª¿è£œããè©Šéšãã¬ãŒãããè©Šéšã
ãèµ€è¡çã®ãã¢ã°ããã³å«éãåžå çã§ããæ³¢é·
ïŒããšãã°ã415nmã®æ³¢é·ãæããéè²å ãé©åœ
ã§ããïŒã«ãããŠéçãŸãã¯èµ°æ»ãã³ã·ãã¡ããª
ãŒã«ãããããšãã§ãããèµ°æ»ãã³ã·ãã¡ããªãŒ
ã¯ã容æã«å ¥æããããšãã§ãäžã€ãããšãã°(1)
第äºã®å±€ãçæããŠãããïŒ(2)ã©ã®äœã®æ°ã®è¡ç
ã第äºã®å±€ãæ§æããŠãããïŒããã³(3)第äºã®å±€
ã®ååžã¯ã©ã®ããã§ãããïŒïŒâååžâãšã¯ç¬¬äº
ã®å±€ã®åäžæ§ã«é¢ããããšã§ããïŒãšãããããª
åé¡ã«å¯Ÿããå®éçãªè§£çãäžããããšãã§ã
ããååã«ç¢ºç«ããè©Šéšè£ 眮ã®äœ¿çšãå å«ããã®
ã¿ã§ãããåäžãªç¬¬äºã®å±€ã¯ãäœçšãããæžæ¿æ¶²
äžã®è¡çã®100ïŒ ã第äžã®å±€ã«å¯ŸããŠçµåããã
ãã«å¿ èŠãªæåãä¿æããŠããããšãæå³ããã®
ã«å¯ŸããŠãäžåäžãªååžãšã¯ãäœçšãããæžæ¿æ¶²
äžã«ããçšåºŠã®âé°æ§âã®è¡çãååšããŠããã
ãšãæå³ããã
现èè¡šé¢äžã®å
ç«åŠçå åãè©äŸ¡åæãããã
ã®äžèšã®ç¬¬äºã®æ¹æ³ã«ãããŠã該溶液ããå ç«åž
çãããæäœãŸãã¯æåã®ååšã¯ãçµåãããå
äžå±€ãæåïŒãŸãã¯æäœïŒæº¶æ¶²ãšåå¿ãçµã€ãã®
ã¡ã«ãè©Šéšãã¹ã现èæ¯éå£ã®ç¬¬äºã®æžæ¿æ¶²ãäœ
çšããäžã€å ¬ç¥ã®ç¹ç°æ§ãæããæåïŒãŸãã¯æ
äœïŒãæ¶æ©å€ãšããŠåãããŠãã第äºã®çŽ°èå±€ã®
çæã枬å®ããããšã«ãã€ãŠãå ·åè¯ãæ€åºãã
ããšãã§ããã
ã®äžèšã®ç¬¬äºã®æ¹æ³ã«ãããŠã該溶液ããå ç«åž
çãããæäœãŸãã¯æåã®ååšã¯ãçµåãããå
äžå±€ãæåïŒãŸãã¯æäœïŒæº¶æ¶²ãšåå¿ãçµã€ãã®
ã¡ã«ãè©Šéšãã¹ã现èæ¯éå£ã®ç¬¬äºã®æžæ¿æ¶²ãäœ
çšããäžã€å ¬ç¥ã®ç¹ç°æ§ãæããæåïŒãŸãã¯æ
äœïŒãæ¶æ©å€ãšããŠåãããŠãã第äºã®çŽ°èå±€ã®
çæã枬å®ããããšã«ãã€ãŠãå ·åè¯ãæ€åºãã
ããšãã§ããã
æ¬çºæã®æ¹æ³ã¯ãæåæ§ãåãåããã®ãšæã
ããææã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²éã®ç«¶äºåå¿ã«å¯Ÿã
ãè©Šéšã®ããã«çšããããšãã§ãããããªãã¡ã
éå¯éçã«çµåãã现èã®åäžå±€ãåèšã®ããã«
ããŠèª¿è£œããã次ãã§ãã®å±€ããçµåãã现èã®
åäžå±€äžãžã®å ç«åžçãå¯èœãªæ¢ç¥ã®ç¹ç°æ§ãæ
ããæåãŸãã¯æäœãå«æããäžæº¶æ¶²ãããã³è©Š
éšãã¹ã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ã®äž¡æº¶æ¶²ã®æ··å
ç©ãšæ¥è§Šãããã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²äžã«å
åšããå åã«ããæ¢ç¥ã®æäœãŸãã¯æåã®ç«¶äºç
çµåã¯ãéå¯éçã«çµåãã现èåäžå±€ãšã®å ç«
åžçåå¿ã®çæã®äœäžã«åæ ããã
ããææã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²éã®ç«¶äºåå¿ã«å¯Ÿã
ãè©Šéšã®ããã«çšããããšãã§ãããããªãã¡ã
éå¯éçã«çµåãã现èã®åäžå±€ãåèšã®ããã«
ããŠèª¿è£œããã次ãã§ãã®å±€ããçµåãã现èã®
åäžå±€äžãžã®å ç«åžçãå¯èœãªæ¢ç¥ã®ç¹ç°æ§ãæ
ããæåãŸãã¯æäœãå«æããäžæº¶æ¶²ãããã³è©Š
éšãã¹ã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ã®äž¡æº¶æ¶²ã®æ··å
ç©ãšæ¥è§Šãããã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²äžã«å
åšããå åã«ããæ¢ç¥ã®æäœãŸãã¯æåã®ç«¶äºç
çµåã¯ãéå¯éçã«çµåãã现èåäžå±€ãšã®å ç«
åžçåå¿ã®çæã®äœäžã«åæ ããã
åèšã®ããã«ãçµåããããæåã®ç¬¬äºã®å±€ã
æãã现èã®åäžå±€ã®èª¿è£œã¯ããã®æ¹æ³ãšäžŠã¶ã
ã®ã§ããããã®å Žåã第äºã®çŽ°èã®åäžå±€ã圢æ
ããããšãã§ãã现èã®æžæ¿æ¶²ããã³è©äŸ¡åæã
ã¹ãæªç¥ã®å åãå«æãã第äºã®æº¶æ¶²ãŸãã¯æžæ¿
液ã®éã®ç«¶äºåå¿ã枬å®ããããããã®äž¡æžæ¿æ¶²
ïŒãŸãã¯æžæ¿æ¶²ãšæº¶æ¶²ïŒã®éã®ç«¶äºçãªå ç«åŠç
åå¿ã®ååšã¯ã第äºã®çŽ°èåäžå±€ã®çæã®äœäžã«
åæ ããã
æãã现èã®åäžå±€ã®èª¿è£œã¯ããã®æ¹æ³ãšäžŠã¶ã
ã®ã§ããããã®å Žåã第äºã®çŽ°èã®åäžå±€ã圢æ
ããããšãã§ãã现èã®æžæ¿æ¶²ããã³è©äŸ¡åæã
ã¹ãæªç¥ã®å åãå«æãã第äºã®æº¶æ¶²ãŸãã¯æžæ¿
液ã®éã®ç«¶äºåå¿ã枬å®ããããããã®äž¡æžæ¿æ¶²
ïŒãŸãã¯æžæ¿æ¶²ãšæº¶æ¶²ïŒã®éã®ç«¶äºçãªå ç«åŠç
åå¿ã®ååšã¯ã第äºã®çŽ°èåäžå±€ã®çæã®äœäžã«
åæ ããã
ãããã®æŠå¿µçãªæéå
ã§ãããã€ãã®ç¹å®ç
ãªè©äŸ¡åææ¹æ³ãè©Šã¿ãããšãã§ããïŒ ïŒ ç«¶äºçå ç«åžçã«ããæåã®è©äŸ¡åæããã®
åæã¯(a)åºäœåºè³ªã«å¯ŸããŠãè©Šéšãã¹ãæåã
ä¿æããŠããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²
ãã該åºè³ªã«è©²è¡çã®å±€ãéå¯éçã«çµåãã
ãããã«æå¹ãªæ¡ä»¶äžã«ãäœçšããïŒ(b)該局(a)
ã(i)該局(a)ã®è¡çãä¿æããæåãšå ç«åžçã«
ãã€ãŠåå¿ããæäœã®æº¶æ¶²ããã³(ii)該溶液äžã®
æäœã®ç«¶äºçãªæå¶ã«ãã€ãŠæåã«ã€ããŠè©äŸ¡
åæãã¹ã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãš
æ¥è§ŠããïŒäžã€(c)ç¶ãã®ã¡ã溶液(i)äžã®è©²æäœ
ã該局(a)ãžã®å ç«åžçã«ãã€ãŠçµåããçšåºŠã
枬å®ããããšãã段éããæã€ãŠããã
ãªè©äŸ¡åææ¹æ³ãè©Šã¿ãããšãã§ããïŒ ïŒ ç«¶äºçå ç«åžçã«ããæåã®è©äŸ¡åæããã®
åæã¯(a)åºäœåºè³ªã«å¯ŸããŠãè©Šéšãã¹ãæåã
ä¿æããŠããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²
ãã該åºè³ªã«è©²è¡çã®å±€ãéå¯éçã«çµåãã
ãããã«æå¹ãªæ¡ä»¶äžã«ãäœçšããïŒ(b)該局(a)
ã(i)該局(a)ã®è¡çãä¿æããæåãšå ç«åžçã«
ãã€ãŠåå¿ããæäœã®æº¶æ¶²ããã³(ii)該溶液äžã®
æäœã®ç«¶äºçãªæå¶ã«ãã€ãŠæåã«ã€ããŠè©äŸ¡
åæãã¹ã第äºã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãš
æ¥è§ŠããïŒäžã€(c)ç¶ãã®ã¡ã溶液(i)äžã®è©²æäœ
ã該局(a)ãžã®å ç«åžçã«ãã€ãŠçµåããçšåºŠã
枬å®ããããšãã段éããæã€ãŠããã
ïŒ ç«¶äºçæå¶ã«ããæåã®è©äŸ¡åæããã®åæ
ã¯(a)åºäœåºè³ªã«å¯ŸããŠãè©Šéšãã¹ãæåãä¿æ
ããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²ãã該åº
質ã«è©²çŽ°èã®åäžå±€ãéå¯éçã«çµåãããã
ãã«æå¹ãªæ¡ä»¶äžã«äœçšããïŒ(b)該局(a)ã«å¯Ÿã
ãŠã該局(a)ã®çŽ°èãä¿æããæåãšå ç«çåžç
ã«ãã€ãŠåå¿ããæäœãå«æãã溶液ãäœçšã
ãïŒäžã€(c)ç¶ãã®ã¡ã(i)該æ¯éå£ã®çŽ°èã®ç¬¬äº
ã®æžæ¿æ¶²ãããã³(ii)該溶液ã®å ç«çã«åžçãã
ããæäœãšç«¶äºçã«åå¿ããæåãå«æãã溶
液ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãäœçšããäžã€è©²ç¬¬äº
ã®æžæ¿æ¶²ã該åºè³ªäžã«çŽ°èã®ç¬¬äºã®å±€ã圢æã
ãçšåºŠã枬å®ããããšãã段éããæã€ãŠã
ãã
ã¯(a)åºäœåºè³ªã«å¯ŸããŠãè©Šéšãã¹ãæåãä¿æ
ããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²ãã該åº
質ã«è©²çŽ°èã®åäžå±€ãéå¯éçã«çµåãããã
ãã«æå¹ãªæ¡ä»¶äžã«äœçšããïŒ(b)該局(a)ã«å¯Ÿã
ãŠã該局(a)ã®çŽ°èãä¿æããæåãšå ç«çåžç
ã«ãã€ãŠåå¿ããæäœãå«æãã溶液ãäœçšã
ãïŒäžã€(c)ç¶ãã®ã¡ã(i)該æ¯éå£ã®çŽ°èã®ç¬¬äº
ã®æžæ¿æ¶²ãããã³(ii)該溶液ã®å ç«çã«åžçãã
ããæäœãšç«¶äºçã«åå¿ããæåãå«æãã溶
液ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãäœçšããäžã€è©²ç¬¬äº
ã®æžæ¿æ¶²ã該åºè³ªäžã«çŽ°èã®ç¬¬äºã®å±€ã圢æã
ãçšåºŠã枬å®ããããšãã段éããæã€ãŠã
ãã
ïŒ çŽ°èæ¯éå£äžã®æäœã®è©äŸ¡åæïŒãã®åæã¯
(a)è©Šéšãã¹ãæ¯éå£ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²ãåº
äœåºè³ªã«å¯ŸããŠè©²çŽ°èã®å±€ã該åºè³ªã«å¯ŸããŠé
å¯éçã«çµåãããããã«æå¹ãªæ¡ä»¶äžã«äœçš
ããïŒ(b)該局(a)ãå ç«çåžçã«ãã€ãŠè©²çŽ°èè¡š
é¢äžã®åæãã¹ãæäœãšåå¿ããæ¢ç¥ã®ç¹ç°æ§
ãæããæåãå«æãã溶液ãšæ¥è§ŠããïŒäžã€
(c)çããå ç«çåžçã®çšåºŠã枬å®ããããšãã
段éããæã€ãŠããã
(a)è©Šéšãã¹ãæ¯éå£ã®çŽ°èã®ç¬¬äžã®æžæ¿æ¶²ãåº
äœåºè³ªã«å¯ŸããŠè©²çŽ°èã®å±€ã該åºè³ªã«å¯ŸããŠé
å¯éçã«çµåãããããã«æå¹ãªæ¡ä»¶äžã«äœçš
ããïŒ(b)該局(a)ãå ç«çåžçã«ãã€ãŠè©²çŽ°èè¡š
é¢äžã®åæãã¹ãæäœãšåå¿ããæ¢ç¥ã®ç¹ç°æ§
ãæããæåãå«æãã溶液ãšæ¥è§ŠããïŒäžã€
(c)çããå ç«çåžçã®çšåºŠã枬å®ããããšãã
段éããæã€ãŠããã
ïŒ çŽ°èæ¯éå£äžã®æäœã®ååšã«ãããæåã«å¯Ÿ
ããè©äŸ¡åæããã®åæã¯(a)åºäœåºè³ªã«å¯Ÿã
ãŠãæäœãä¿æããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®
æžæ¿æ¶²ã該åºè³ªãžã®è©²çŽ°èã®å±€ã®éå¯éçãªçµ
åã«å¯ŸããŠæå¹ãªæ¡ä»¶äžã«äœçšããïŒ(b)該局(a)
ã(i)æåã«å¯ŸããŠè©äŸ¡åæãã¹ã溶液ãããã³
(ii)競äºçæå¶ã«ããè©äŸ¡åæãã¹ãæåãšå ç«
åžçã«ãã€ãŠåå¿ããæäœãå«æãã第äºã®æº¶
液ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãšæ¥è§ŠããïŒäžã€(c)ç¶
ãã®ã¡æº¶æ¶²(i)äžã®è©²æåãå ç«åžçã«ãã€ãŠè©²
å±€(a)ã«å¯ŸããŠçµåããçšåºŠã枬å®ããããšãã
段éããæã€ãŠããã
ããè©äŸ¡åæããã®åæã¯(a)åºäœåºè³ªã«å¯Ÿã
ãŠãæäœãä¿æããããšãæ¢ç¥ã®çŽ°èã®ç¬¬äžã®
æžæ¿æ¶²ã該åºè³ªãžã®è©²çŽ°èã®å±€ã®éå¯éçãªçµ
åã«å¯ŸããŠæå¹ãªæ¡ä»¶äžã«äœçšããïŒ(b)該局(a)
ã(i)æåã«å¯ŸããŠè©äŸ¡åæãã¹ã溶液ãããã³
(ii)競äºçæå¶ã«ããè©äŸ¡åæãã¹ãæåãšå ç«
åžçã«ãã€ãŠåå¿ããæäœãå«æãã第äºã®æº¶
液ãŸãã¯æžæ¿æ¶²ã®æ··åç©ãšæ¥è§ŠããïŒäžã€(c)ç¶
ãã®ã¡æº¶æ¶²(i)äžã®è©²æåãå ç«åžçã«ãã€ãŠè©²
å±€(a)ã«å¯ŸããŠçµåããçšåºŠã枬å®ããããšãã
段éããæã€ãŠããã
äžèšã®æ¹æ³ã®äœãã«ãããŠããå
ç«åžçã®çšåºŠ
ã¯ãå ã«æŠèª¬ããæ¹æ³ã®äžã®äžã€ãŸãã¯ãããã
ãå€ãã«ãã€ãŠæž¬å®ããããšãã§ããã
ã¯ãå ã«æŠèª¬ããæ¹æ³ã®äžã®äžã€ãŸãã¯ãããã
ãå€ãã«ãã€ãŠæž¬å®ããããšãã§ããã
åŸæ¥ã®æè¡ã®èšè¿°
è¡æ¶²è²¯èµè¡æž
åŠã«äŒŽãªãå€ãããã®å»çäžã®å
é¡ãããã³æ¹æ³ãæ¹è¯ãäžã€ãããã®æ¹æ³ãæ©åš
䜿çšããã³èªååå¯èœãªãã®ãšãªããããããšã®
å¿ èŠãããã«ããããããããã®åéã«ãããåŸ
æ¥ã®æè¡ã¯ãã»ãšãã©å©ããšã¯ãªããªãã€ããå€
幎ã«ããããè¡æ¶²åå€å®è©Šéšã®ããã®ãããã
âãšã«ãã³âïŒEldonïŒã«ãŒããç¥ãããŠãããã
ããã¯ãããšãã°ãã¢ã¡ãªã«åè¡åœç¹èš±ç¬¬
2770572å·äžã«èšãããŠããã該ç¹èš±ã¯ãè ççŽ
ãŸãã¯è ççŽ ä»£çšåãšã®æ··åç©ãšããŠæäœå åã
å«æããè©Šéšè¡æž ã®ä¹Ÿç¥ããè©Šæãè¡šé¢ã®ç°ãªã
éšåã«ä¿æããŠããæ¯æã«ãŒãããæã人éã®è¡
液åã®å€å®ã«ãããŠäœ¿çšããããã®è©Šéšã«ãŒãã
èšããŠããããšã«ãã³ã«ãŒãã䜿çšããŠè¡æ¶²åå€
å®è©Šéšãè¡ãªãã«ã¯ãè¡æ¶²åãå€å®ãã¹ãæ£è ã
ãã®è¡æ¶²è©Šæããã«ãŒãäžã«å«ãŸãããããããª
è¡æž ã¹ãããäžã«å°æ»ŽãšããŠæ»Žäžãäžã€é©åœãªå
å¿æéã®æŸçœ®åŸã«ãåéã®ååšãŸãã¯äžåšã調ã¹
ããããããªããããã®è©Šéšã¯ãæâãæâ
ããã³æâRhïŒRhoãŸãã¯ïŒ€ïŒã«éå®ãããäž
ã€ãããã§ãããå€æã®å€§ããªèª€ãŸãã䌎ãªãã
ãšãããã
é¡ãããã³æ¹æ³ãæ¹è¯ãäžã€ãããã®æ¹æ³ãæ©åš
䜿çšããã³èªååå¯èœãªãã®ãšãªããããããšã®
å¿ èŠãããã«ããããããããã®åéã«ãããåŸ
æ¥ã®æè¡ã¯ãã»ãšãã©å©ããšã¯ãªããªãã€ããå€
幎ã«ããããè¡æ¶²åå€å®è©Šéšã®ããã®ãããã
âãšã«ãã³âïŒEldonïŒã«ãŒããç¥ãããŠãããã
ããã¯ãããšãã°ãã¢ã¡ãªã«åè¡åœç¹èš±ç¬¬
2770572å·äžã«èšãããŠããã該ç¹èš±ã¯ãè ççŽ
ãŸãã¯è ççŽ ä»£çšåãšã®æ··åç©ãšããŠæäœå åã
å«æããè©Šéšè¡æž ã®ä¹Ÿç¥ããè©Šæãè¡šé¢ã®ç°ãªã
éšåã«ä¿æããŠããæ¯æã«ãŒãããæã人éã®è¡
液åã®å€å®ã«ãããŠäœ¿çšããããã®è©Šéšã«ãŒãã
èšããŠããããšã«ãã³ã«ãŒãã䜿çšããŠè¡æ¶²åå€
å®è©Šéšãè¡ãªãã«ã¯ãè¡æ¶²åãå€å®ãã¹ãæ£è ã
ãã®è¡æ¶²è©Šæããã«ãŒãäžã«å«ãŸãããããããª
è¡æž ã¹ãããäžã«å°æ»ŽãšããŠæ»Žäžãäžã€é©åœãªå
å¿æéã®æŸçœ®åŸã«ãåéã®ååšãŸãã¯äžåšã調ã¹
ããããããªããããã®è©Šéšã¯ãæâãæâ
ããã³æâRhïŒRhoãŸãã¯ïŒ€ïŒã«éå®ãããäž
ã€ãããã§ãããå€æã®å€§ããªèª€ãŸãã䌎ãªãã
ãšãããã
ããã«æè¿ããã©ã€ã¹ïŒR.T.PriceïŒã¯ãã¢ã¡
ãªã«åè¡åœç¹èš±3666421å·ã«ãããŠãããäžã€ã®
éå¥è©Šéšã¹ã©ã€ãã«ã€ããŠèšããŠãããããã®å Ž
åã«ã¯ãè¡æž åŠçãªè©Šå€ãã液滎ãšããŠè©Šéšã¹ã©
ã€ãäžã«æ»Žäžãäžã€ã¹ããããšããŠä¹Ÿç¥ãããã®
ã§ãããããã®ã¹ãããã¯åŸã«åçããŠãè¡æ¶²å
ã®å€å®ã®ããã®åéåå¿ïŒãŸãã¯åéã«ãã€ãŠå€
å®ã§ãããã®ä»ã®æåâæäœåå¿ç³»ïŒã«ãããŠå
å¿ããããããšãã§ãããããããªãããã©ã€ã¹
ã«ãã€ãŠèšãããŠããè©Šéšã¹ã©ã€ãã¯ãéåžžã®æ¶²
çžåéã®æããæ¬ ç¹ããŸã¬ãããããšã¯ã§ããª
ãïŒãã®è©Šéšã¯æ¬è³ªçã«åéã®ååšãŸãã¯äžåšã
瀺ãã®ã¿ã§ããäžã€åéãç¹ç°çãªæåâæäœå
å¿ã®çµæã§ãããããŸãã¯åã«éç¹ç°çãªçŽ°èå
éã®çµæã§ãããã®äœããã決å®ããããã«ãç
ç·Žããæè¡è ã«ããè©äŸ¡ã«ããã€ãŠããïŒç¹ç°ç
ãªåéåå¿ã«ããåéãã现èãšå ±ã«ãéé¢ã®é
åé现èãååšããŠãããã©ãããè©äŸ¡ããããš
ã¯ãå°é£ã§ããããŸãã¯äžå¯èœã§ããã
ãªã«åè¡åœç¹èš±3666421å·ã«ãããŠãããäžã€ã®
éå¥è©Šéšã¹ã©ã€ãã«ã€ããŠèšããŠãããããã®å Ž
åã«ã¯ãè¡æž åŠçãªè©Šå€ãã液滎ãšããŠè©Šéšã¹ã©
ã€ãäžã«æ»Žäžãäžã€ã¹ããããšããŠä¹Ÿç¥ãããã®
ã§ãããããã®ã¹ãããã¯åŸã«åçããŠãè¡æ¶²å
ã®å€å®ã®ããã®åéåå¿ïŒãŸãã¯åéã«ãã€ãŠå€
å®ã§ãããã®ä»ã®æåâæäœåå¿ç³»ïŒã«ãããŠå
å¿ããããããšãã§ãããããããªãããã©ã€ã¹
ã«ãã€ãŠèšãããŠããè©Šéšã¹ã©ã€ãã¯ãéåžžã®æ¶²
çžåéã®æããæ¬ ç¹ããŸã¬ãããããšã¯ã§ããª
ãïŒãã®è©Šéšã¯æ¬è³ªçã«åéã®ååšãŸãã¯äžåšã
瀺ãã®ã¿ã§ããäžã€åéãç¹ç°çãªæåâæäœå
å¿ã®çµæã§ãããããŸãã¯åã«éç¹ç°çãªçŽ°èå
éã®çµæã§ãããã®äœããã決å®ããããã«ãç
ç·Žããæè¡è ã«ããè©äŸ¡ã«ããã€ãŠããïŒç¹ç°ç
ãªåéåå¿ã«ããåéãã现èãšå ±ã«ãéé¢ã®é
åé现èãååšããŠãããã©ãããè©äŸ¡ããããš
ã¯ãå°é£ã§ããããŸãã¯äžå¯èœã§ããã
ã¹ãã¹ïŒJ.E.SmithïŒã¯ã¢ã¡ãªã«åè¡åœç¹èš±
3770380å·ã«ãããŠãå ç«ççåå¿ãè©äŸ¡ããã
ãã«ææ¡ããè£ çœ®ã«ã€ããŠèšããŠãããã¹ãã¹ã®
ç¹èš±ã«é¢ããå ç«ççåå¿ãšã¯ãæ¬çºæã®åºç€ãš
ãªãå ç«åžççŸè±¡ãšã¯ç°ãªããã®ã§ãããšããã
ãšãããã®é泚æãã¹ãã§ãããå ç«ççã¯ãè£
äœã®ååšã«ããç²åããªãã¡çŽ°èã®éç¹ç°çãªå
éã§ããïŒå ç«ççã«ãããŠã¯ãçµåãçããã
ããã®ã¯è£äœã§ãããå ç«ççã¯ãè£äœããã³ã
ããçµåãã¹ãç²åããªãã¡çŽ°èã®éã®éç¹ç°ç
ãªåå¿ã§ãããšããç¹ã«ç¹åŸŽããããããã«å¯Ÿã
ãŠãå ç«åžçã¯çŽ°èèäžã®æåæ§ã®ç¹ãšè¡æž äžã«
ååšããæäœã®éã®ç¹ç°çãªçµåã§ãããããã
ãŠãå ç«åžçã¯ãå ç«ççãšã¯ç°ãªã€ãŠãæåãš
æäœã®éã®ç¹ç°çãªçµåã«é¢ãããã®ã§ããã
3770380å·ã«ãããŠãå ç«ççåå¿ãè©äŸ¡ããã
ãã«ææ¡ããè£ çœ®ã«ã€ããŠèšããŠãããã¹ãã¹ã®
ç¹èš±ã«é¢ããå ç«ççåå¿ãšã¯ãæ¬çºæã®åºç€ãš
ãªãå ç«åžççŸè±¡ãšã¯ç°ãªããã®ã§ãããšããã
ãšãããã®é泚æãã¹ãã§ãããå ç«ççã¯ãè£
äœã®ååšã«ããç²åããªãã¡çŽ°èã®éç¹ç°çãªå
éã§ããïŒå ç«ççã«ãããŠã¯ãçµåãçããã
ããã®ã¯è£äœã§ãããå ç«ççã¯ãè£äœããã³ã
ããçµåãã¹ãç²åããªãã¡çŽ°èã®éã®éç¹ç°ç
ãªåå¿ã§ãããšããç¹ã«ç¹åŸŽããããããã«å¯Ÿã
ãŠãå ç«åžçã¯çŽ°èèäžã®æåæ§ã®ç¹ãšè¡æž äžã«
ååšããæäœã®éã®ç¹ç°çãªçµåã§ãããããã
ãŠãå ç«åžçã¯ãå ç«ççãšã¯ç°ãªã€ãŠãæåãš
æäœã®éã®ç¹ç°çãªçµåã«é¢ãããã®ã§ããã
ã¹ãã¹ã®èšããŠããåšå
·ã¯ãå¹³ããå°å®€ç¶ã®æ§
é ç©ã§ããããã®åºäžã«ã¯äžéšè¢«èŠãšããŠã®çŽ°è
ãŸãã¯ããŒã«ã¹æ§ææã®é£ç¶çã³ãŒãã€ã³ã°ãæœ
ãããŠããããã®äžéšè¢«èŠã¯éæãªã也ç¥ããè
çœè³ªäžå±€ã«ãã€ãŠå°å®€ã®åºã«çµåããããŠããã
ããããŠèª¿è£œããå°å®€ã®çŽ°èãŸãã¯ããŒã«ã¹ãšã
ããã«å¯ŸããŠäœçšãããè©Šéšæ¶²äœäžã®æäœããã³
è£äœãä¿æããèµ€è¡çã®éã®å ç«ççåå¿ãã次
ãã§ãç¹å¥ã«çšæããäœçšæ¶²äœäžã®èµ€è¡çã现è
ãŸãã¯ããŒã«ã¹å«æäžéšè¢«èŠã«ä»çããçšåºŠã枬
å®ããããšã«ãã€ãŠè©äŸ¡ãããã¹ãã¹ãè¿°ã¹ãŠã
ãæ¹æ³ã¯ãå ç«ççèªäœãåºãæ¡æãããŠã¯ãã
ãäžã€ãŸããå ç«ççã¯éç¹ç°çã§ãããããç¹
ç°çæåâæäœåå¿ã®è©äŸ¡ã«ã¯é©ããŠããªããšã
ãçç±ã«ãã€ãŠãå®éçãªå»çäžã®äŸ¡å€ãèªãã
ããŠããªãã
é ç©ã§ããããã®åºäžã«ã¯äžéšè¢«èŠãšããŠã®çŽ°è
ãŸãã¯ããŒã«ã¹æ§ææã®é£ç¶çã³ãŒãã€ã³ã°ãæœ
ãããŠããããã®äžéšè¢«èŠã¯éæãªã也ç¥ããè
çœè³ªäžå±€ã«ãã€ãŠå°å®€ã®åºã«çµåããããŠããã
ããããŠèª¿è£œããå°å®€ã®çŽ°èãŸãã¯ããŒã«ã¹ãšã
ããã«å¯ŸããŠäœçšãããè©Šéšæ¶²äœäžã®æäœããã³
è£äœãä¿æããèµ€è¡çã®éã®å ç«ççåå¿ãã次
ãã§ãç¹å¥ã«çšæããäœçšæ¶²äœäžã®èµ€è¡çã现è
ãŸãã¯ããŒã«ã¹å«æäžéšè¢«èŠã«ä»çããçšåºŠã枬
å®ããããšã«ãã€ãŠè©äŸ¡ãããã¹ãã¹ãè¿°ã¹ãŠã
ãæ¹æ³ã¯ãå ç«ççèªäœãåºãæ¡æãããŠã¯ãã
ãäžã€ãŸããå ç«ççã¯éç¹ç°çã§ãããããç¹
ç°çæåâæäœåå¿ã®è©äŸ¡ã«ã¯é©ããŠããªããšã
ãçç±ã«ãã€ãŠãå®éçãªå»çäžã®äŸ¡å€ãèªãã
ããŠããªãã
åºäœæ¯æäœäžã«åã蟌ãã è¡çã®å±€ãè¡æ¶²åå€
å®ããã³é©åæ§è©Šéšãšã¯é¢ä¿ãªããç§åŠçãªç®ç
ã®ããã«çšããããŠããããã®ãããªå±€ã¯å ±æå
å䟡ãŸãã¯ãã®ä»ã®ååéåã«ãã€ãŠçµåããŠã¯
ããªããããªãã¡ãã°ãããã³ïŒGoodmanã
Natureã193ïŒ350ã1962ïŒã¯ãããªãŠã¬ã¿ã³äž
ã«åã蟌ãã ãã«ããªã³åŠçãã人éã®èµ€è¡çã®
ã«ã©ã ã調補ãããããã人éã®æâèµ€è¡çæäœ
ã®åã蟌ãŸããèµ€è¡çã«å¯Ÿããçµåã®åŒ·ãã«åºã¥
ããŠãåè ãåå¥ããããã«äœ¿çšããããšãŒãã«
ãã³ãïŒEdelman et alãProc.Nat.Acad.Sci.ã
68ïŒ2153ã1971ïŒã¯ãéšåçã«å æ°Žå解ãããã€
ãã³ç¹ç¶ã«å¯ŸããŠäºãçµåãããŠããã¬ã¯ãã³ã
æäœãŸãã¯æåã«å¯ŸããŠç¹ç°çã«çµåããè¡çã®
èœåã«åºã¥ããŠãè¡çãåå¥ããã
å®ããã³é©åæ§è©Šéšãšã¯é¢ä¿ãªããç§åŠçãªç®ç
ã®ããã«çšããããŠããããã®ãããªå±€ã¯å ±æå
å䟡ãŸãã¯ãã®ä»ã®ååéåã«ãã€ãŠçµåããŠã¯
ããªããããªãã¡ãã°ãããã³ïŒGoodmanã
Natureã193ïŒ350ã1962ïŒã¯ãããªãŠã¬ã¿ã³äž
ã«åã蟌ãã ãã«ããªã³åŠçãã人éã®èµ€è¡çã®
ã«ã©ã ã調補ãããããã人éã®æâèµ€è¡çæäœ
ã®åã蟌ãŸããèµ€è¡çã«å¯Ÿããçµåã®åŒ·ãã«åºã¥
ããŠãåè ãåå¥ããããã«äœ¿çšããããšãŒãã«
ãã³ãïŒEdelman et alãProc.Nat.Acad.Sci.ã
68ïŒ2153ã1971ïŒã¯ãéšåçã«å æ°Žå解ãããã€
ãã³ç¹ç¶ã«å¯ŸããŠäºãçµåãããŠããã¬ã¯ãã³ã
æäœãŸãã¯æåã«å¯ŸããŠç¹ç°çã«çµåããè¡çã®
èœåã«åºã¥ããŠãè¡çãåå¥ããã
é
å矀ïŒæåãæäœãé
µçŽ ãªã©ã®ïŒåºäœåºè³ªãž
ã®çµåã®åçã¯ããã確ç«ãããçååŠçãªæ¹æ³
ïŒCautrecases ããã³AnfinsenãAnnu.Rev.
Biochem.ã40ïŒ259ã1971åç §ïŒã§ãããåºçžæŸ
å°ç·å ç«è©äŸ¡åææ¹æ³ã«ãããŠåºãçšããããŠã
ãïŒBrit.Med.Bull.ã30ïŒïŒã103ã1974åç §ïŒã
ããããªãããè¡æ¶²ãŸãã¯ãã®ä»ã®çŽ°èããåºäœ
åºè³ªã«éå¯éçã«çµåãããŠè¡æ¶²ãŸãã¯çµç¹ã®å
ã®å€å®ãé©åæ§è©Šéšãªã©ã容æã«ããããšã¯æªã
è¡ãªãããŠããªãã
ã®çµåã®åçã¯ããã確ç«ãããçååŠçãªæ¹æ³
ïŒCautrecases ããã³AnfinsenãAnnu.Rev.
Biochem.ã40ïŒ259ã1971åç §ïŒã§ãããåºçžæŸ
å°ç·å ç«è©äŸ¡åææ¹æ³ã«ãããŠåºãçšããããŠã
ãïŒBrit.Med.Bull.ã30ïŒïŒã103ã1974åç §ïŒã
ããããªãããè¡æ¶²ãŸãã¯ãã®ä»ã®çŽ°èããåºäœ
åºè³ªã«éå¯éçã«çµåãããŠè¡æ¶²ãŸãã¯çµç¹ã®å
ã®å€å®ãé©åæ§è©Šéšãªã©ã容æã«ããããšã¯æªã
è¡ãªãããŠããªãã
æ¬çºæã®è©³çŽ°ãªèª¬æ
以äžã«ãããŠãçŸåšè¡ãªãããŠããèµ€è¡çã®è©Š
éšã«é¢ããŠæ¬çºæã説æãããããªã¹ãã¬ã³è©Šéš
管ããéå¯éçã«çµåããç·ç¶çŽ åïŒ0.5mgïŒml
䜿çšïŒã«ãã€ãŠè¢«èŠãããæŽæµåŸã«ãçµåããç·
ç¶çŽ åã«å¯ŸããŠããªãªãžã³ïŒ0.1mgïŒmlïŒãäœçš
ããããåã³æŽæµããã®ã¡ãæ£åžžã®ãŸãã¯èçœé µ
çŽ åŠçããèµ€è¡çïŒRBCïŒã®ã©ã¡ããã®æžæ¿æ¶²
ãå°å ¥ããããããã®RBCã¯ãããªãªãžã³äžç·
ç¶çŽ å被èŠããããªã¹ãã¬ã³è¡šé¢ã«å¯ŸããŠåäžå±€
ãšããŠéå¯éçã«çµåããïŒè©Šéšã®ããã«ïŒãå¹³
æ¹ã»ã³ãã¡ãŒãã«åœãïŒÃ106RBCãšããçµåå¯
床ã¯ãïŒãã¯ãã¡ãŒãã«ã®çŽåŸãæããRBCã«
察ããŠäºæž¬ãããå€ãšããäžèŽããŠããã
éšã«é¢ããŠæ¬çºæã説æãããããªã¹ãã¬ã³è©Šéš
管ããéå¯éçã«çµåããç·ç¶çŽ åïŒ0.5mgïŒml
䜿çšïŒã«ãã€ãŠè¢«èŠãããæŽæµåŸã«ãçµåããç·
ç¶çŽ åã«å¯ŸããŠããªãªãžã³ïŒ0.1mgïŒmlïŒãäœçš
ããããåã³æŽæµããã®ã¡ãæ£åžžã®ãŸãã¯èçœé µ
çŽ åŠçããèµ€è¡çïŒRBCïŒã®ã©ã¡ããã®æžæ¿æ¶²
ãå°å ¥ããããããã®RBCã¯ãããªãªãžã³äžç·
ç¶çŽ å被èŠããããªã¹ãã¬ã³è¡šé¢ã«å¯ŸããŠåäžå±€
ãšããŠéå¯éçã«çµåããïŒè©Šéšã®ããã«ïŒãå¹³
æ¹ã»ã³ãã¡ãŒãã«åœãïŒÃ106RBCãšããçµåå¯
床ã¯ãïŒãã¯ãã¡ãŒãã«ã®çŽåŸãæããRBCã«
察ããŠäºæž¬ãããå€ãšããäžèŽããŠããã
çµåããRBCã®åäžå±€ã¯ãå®å®ã§ããäžã€ã
äžæ¹ã«ãããŠãçµåããRBCã®çŽ°èèäžæåæ§
ã®ç¹ã«å¯ŸããŠç¹ç°çã§ããäœããã®äœçšæº¶æ¶²ïŒãŸ
ãã¯è¡æž ïŒããã®æäœãçµåããããã®å ç«åžç
åªãšããŠåããã
äžæ¹ã«ãããŠãçµåããRBCã®çŽ°èèäžæåæ§
ã®ç¹ã«å¯ŸããŠç¹ç°çã§ããäœããã®äœçšæº¶æ¶²ïŒãŸ
ãã¯è¡æž ïŒããã®æäœãçµåããããã®å ç«åžç
åªãšããŠåããã
åºäœåºè³ªäžã«åäžå±€ãšããŠè¡çãçµåãããã
ãã®æ¹æ³ã¯äžèšã®æ¹æ³ã«éãå¿ èŠã¯ãªããèçœè³ª
ãéåäœã«ã«ãããªã³ã°ãããããšã«é¢ããæç®
ïŒCuatrecasesããã³AnfinsenãAnnu.Rev.
Biochem.ã40ïŒ259ã1971åç §ïŒã¯ãå¥ã®æ¹æ³ãš
ããŠãè¡šé¢äžã«ããšãã°ã°ã«ã¿ã«ã¢ã«ããããè
åã·ã¢ã³ãã¢ãããŸãã¯ã«ã«ããã·ã«åºã®ãããª
åå¿æ§ã®åºããã³åºè³ªã«å¯Ÿããè¡çã®çŽæ¥çãªå ±
æçµåã«ããã«ãããªã³ã°ãå¯èœãšãããã®ä»ã®
åºãå«æããŠããéåäœã®èª¿è£œåïŒããªãŠã¬ã¿
ã³ãããªã¹ãã¬ã³ãªã©ã®ã·ãŒãïŒãçšããããšã
ã§ãããšããããšã瀺ããŠãããçµåããç©è³ª
ã¯ãç®çãšããè©Šéšæº¶æ¶²äžã«ååšããå¯èœæ§ã®ã
ããã¹ãŠã®æåãŸãã¯æäœã«å¯ŸããŠå ç«åŠçã«äž
掻æ§ã§ãªããã°ãªããªããšããããšã¯ãããŸã§ã
ãªãã
ãã®æ¹æ³ã¯äžèšã®æ¹æ³ã«éãå¿ èŠã¯ãªããèçœè³ª
ãéåäœã«ã«ãããªã³ã°ãããããšã«é¢ããæç®
ïŒCuatrecasesããã³AnfinsenãAnnu.Rev.
Biochem.ã40ïŒ259ã1971åç §ïŒã¯ãå¥ã®æ¹æ³ãš
ããŠãè¡šé¢äžã«ããšãã°ã°ã«ã¿ã«ã¢ã«ããããè
åã·ã¢ã³ãã¢ãããŸãã¯ã«ã«ããã·ã«åºã®ãããª
åå¿æ§ã®åºããã³åºè³ªã«å¯Ÿããè¡çã®çŽæ¥çãªå ±
æçµåã«ããã«ãããªã³ã°ãå¯èœãšãããã®ä»ã®
åºãå«æããŠããéåäœã®èª¿è£œåïŒããªãŠã¬ã¿
ã³ãããªã¹ãã¬ã³ãªã©ã®ã·ãŒãïŒãçšããããšã
ã§ãããšããããšã瀺ããŠãããçµåããç©è³ª
ã¯ãç®çãšããè©Šéšæº¶æ¶²äžã«ååšããå¯èœæ§ã®ã
ããã¹ãŠã®æåãŸãã¯æäœã«å¯ŸããŠå ç«åŠçã«äž
掻æ§ã§ãªããã°ãªããªããšããããšã¯ãããŸã§ã
ãªãã
æ¬çºæã«ãããŠäœ¿çšããããã®ãã®ä»ã®åºè³ªã
ãªãã¡ãããªãã¯ã¹ãšããŠã¯ã(i)åèšã®ããã«ã
ããã«å¯ŸããŠçŽ°èã®åäžå±€ãéå¯éçã«çµåãã
ãããšãã§ãããããªæ§è³ªã®ãã®ã§ããïŒäžã€(ii)
䜿çšãã¹ãæ€åºæ¹æ³ã®ç¹ããã䜿çšã«é©ããŠã
ããäœããã®äŸ¿å®ã®ææãšããããšãã§ãããã
ã€ãšã奜éœåãªæ€åºæ¹æ³ã¯ãããšãã°é¡åŸ®é¡çãª
èšæ°ããã³æ¿åºŠèšã«ããèµ°æ»ãšãããããªãå ã®
ééã«åºã¥ããã®ã§ãããããå ééæ§ã®ç©è³ªã
䜿çšããããšã奜é©ã§ãããããããªãããæŸå°
èœã®èšæ°ãçšããå Žåã¯ãå ééæ§ã®ææã®äœ¿çš
ã¯ããããŸã§ããªãäžå¿ èŠã§ããã
ãªãã¡ãããªãã¯ã¹ãšããŠã¯ã(i)åèšã®ããã«ã
ããã«å¯ŸããŠçŽ°èã®åäžå±€ãéå¯éçã«çµåãã
ãããšãã§ãããããªæ§è³ªã®ãã®ã§ããïŒäžã€(ii)
䜿çšãã¹ãæ€åºæ¹æ³ã®ç¹ããã䜿çšã«é©ããŠã
ããäœããã®äŸ¿å®ã®ææãšããããšãã§ãããã
ã€ãšã奜éœåãªæ€åºæ¹æ³ã¯ãããšãã°é¡åŸ®é¡çãª
èšæ°ããã³æ¿åºŠèšã«ããèµ°æ»ãšãããããªãå ã®
ééã«åºã¥ããã®ã§ãããããå ééæ§ã®ç©è³ªã
䜿çšããããšã奜é©ã§ãããããããªãããæŸå°
èœã®èšæ°ãçšããå Žåã¯ãå ééæ§ã®ææã®äœ¿çš
ã¯ããããŸã§ããªãäžå¿ èŠã§ããã
æ¬çºæã®ç®çã«å¯ŸããŠã¯ãåºè³ªããªãã¡ãããª
ãã¯ã¹ã¯ãåã«è©Šéšç®¡ã®å è¡šé¢ã§ããã°ãããè©Š
éšçµæã®è©äŸ¡ã®ããã«æ¿åºŠèšã«ããèµ°æ»ã®æ¹æ³ã
çšããå Žåã¯ãå¹³ããªè¡šé¢ãé©åœã§ããã倧èŠæš¡
ã®è©Šéšã®ããã«ã¯ã现èçµåæ§ãæããåºè³ªã®ã¹
ããªãããçšããŠç¬¬äžã®çŽ°èå±€ã調補ããããã
ãšãã§ãããç¶ããŠãæäœãã¹ããããããäžã€
è£äœã®ååšã«ãããŠå ç«åŽ©å£ãå©ããããŸãã¯æª
ç¥ã®åã®çŽ°èã®ç¬¬äºã®å±€ãçµåãããã®ã©ã¡ãã
ã«å¯Ÿãããããã®èœåãè©Šéšããããšãã§ããã
äœãã®è©Šéšã®å®éçãªçµæãã厩å£ã瀺ãè²ã®äœ
äžããã³èµ€è¡çã®ç¬¬äºã®å±€ã®çµåã瀺ãè²ã®å¢å€§
ãçšããŠãèµ°æ»ãã³ã·ãã¡ããªãŒã«ãã€ãŠæž¬å®ã
ãããšãã§ãããåŸè ã«å¯ŸããŠã¯ã第äžã®è¡çå±€
ã«ããèæ¯ãå·®åŒãå¿ èŠããªãããã«ãã¹ããã
調補ã®äžéšãšããŠã第äžã®è¡çå±€ãäœåŒµçã«æº¶è§£
ããããšãé©åœã§ããããç¥ããªããäœåŒµç溶解
ã¯ãèã«çµåããæäœã®å€ããèããé€å»ããã
ãšã¯ãªããäžã€ç¬¬äºã®å±€ã®åœ¢æãããã®ãã¢ã°ã
ãã³å«éã«ãã€ãŠãç®èŠã«ãããŸãã¯å åŠçãã³
ã·ãã¡ããªãŒã«ããæ€åºããããšãã§ãããèµ°æ»
ãã³ã·ãã¡ããªãŒãçšããããšã«ãã€ãŠãããšã
ã°ã415nmã«ãããå®éçãªå¿çãã第äºã®å±€ã
çæããŠãããïŒïŒã©ã®çšåºŠã®æ°ã®è¡çïŒæçœãª
極倧ã«ãã€ãŠïŒã第äºã®å±€ãæ§æããŠãããïŒïŒ
第äºã®å±€ã®ååžã¯ã©ã®ãããªãã®ãïŒãšãããã
ãªè³ªåã«å¯ŸããŠãååŸããããšãã§ããã
ãã¯ã¹ã¯ãåã«è©Šéšç®¡ã®å è¡šé¢ã§ããã°ãããè©Š
éšçµæã®è©äŸ¡ã®ããã«æ¿åºŠèšã«ããèµ°æ»ã®æ¹æ³ã
çšããå Žåã¯ãå¹³ããªè¡šé¢ãé©åœã§ããã倧èŠæš¡
ã®è©Šéšã®ããã«ã¯ã现èçµåæ§ãæããåºè³ªã®ã¹
ããªãããçšããŠç¬¬äžã®çŽ°èå±€ã調補ããããã
ãšãã§ãããç¶ããŠãæäœãã¹ããããããäžã€
è£äœã®ååšã«ãããŠå ç«åŽ©å£ãå©ããããŸãã¯æª
ç¥ã®åã®çŽ°èã®ç¬¬äºã®å±€ãçµåãããã®ã©ã¡ãã
ã«å¯Ÿãããããã®èœåãè©Šéšããããšãã§ããã
äœãã®è©Šéšã®å®éçãªçµæãã厩å£ã瀺ãè²ã®äœ
äžããã³èµ€è¡çã®ç¬¬äºã®å±€ã®çµåã瀺ãè²ã®å¢å€§
ãçšããŠãèµ°æ»ãã³ã·ãã¡ããªãŒã«ãã€ãŠæž¬å®ã
ãããšãã§ãããåŸè ã«å¯ŸããŠã¯ã第äžã®è¡çå±€
ã«ããèæ¯ãå·®åŒãå¿ èŠããªãããã«ãã¹ããã
調補ã®äžéšãšããŠã第äžã®è¡çå±€ãäœåŒµçã«æº¶è§£
ããããšãé©åœã§ããããç¥ããªããäœåŒµç溶解
ã¯ãèã«çµåããæäœã®å€ããèããé€å»ããã
ãšã¯ãªããäžã€ç¬¬äºã®å±€ã®åœ¢æãããã®ãã¢ã°ã
ãã³å«éã«ãã€ãŠãç®èŠã«ãããŸãã¯å åŠçãã³
ã·ãã¡ããªãŒã«ããæ€åºããããšãã§ãããèµ°æ»
ãã³ã·ãã¡ããªãŒãçšããããšã«ãã€ãŠãããšã
ã°ã415nmã«ãããå®éçãªå¿çãã第äºã®å±€ã
çæããŠãããïŒïŒã©ã®çšåºŠã®æ°ã®è¡çïŒæçœãª
極倧ã«ãã€ãŠïŒã第äºã®å±€ãæ§æããŠãããïŒïŒ
第äºã®å±€ã®ååžã¯ã©ã®ãããªãã®ãïŒãšãããã
ãªè³ªåã«å¯ŸããŠãååŸããããšãã§ããã
æåŸã®è³ªåã«çããããã«ã¯ãæäœè¢«èŠããå
äžå±€ã«äœçšãããè¡çæžæ¿æ¶²ã¯ç¬¬äºã®åäžå±€ã®æ²
éãå¯èœãšããããã«ã¡ããã©ååãªæ¿åºŠãæã
ãŠããªããã°ãªããªãããããŠã第äºã®å±€ãæŽæµ
ããŠéçµåè¡çãé€ãã°ããã®æŽæµåŸã«ã第äºã®
å±€ã®çµåéšåã®ååžã¯ãä»çããâéœæ§âã®è¡ç
ããã³ä»çããªãâé°æ§âã®è¡çã®çŸåçã®é¢æ°
ãšãªããçããç©Žãããã¯å³¶ã¯ãé¡åŸ®é¡çèµ°æ»ã
ã³ã·ãã¡ããªãŒã§æ€åºããããšãã§ããäžã€ãã
ãã®é »åºŠããã³çšåºŠã¯ãèµ°æ»ããè¡šé¢ã®æ¯ãšããŠ
è¡šããããšãã§ããã
äžå±€ã«äœçšãããè¡çæžæ¿æ¶²ã¯ç¬¬äºã®åäžå±€ã®æ²
éãå¯èœãšããããã«ã¡ããã©ååãªæ¿åºŠãæã
ãŠããªããã°ãªããªãããããŠã第äºã®å±€ãæŽæµ
ããŠéçµåè¡çãé€ãã°ããã®æŽæµåŸã«ã第äºã®
å±€ã®çµåéšåã®ååžã¯ãä»çããâéœæ§âã®è¡ç
ããã³ä»çããªãâé°æ§âã®è¡çã®çŸåçã®é¢æ°
ãšãªããçããç©Žãããã¯å³¶ã¯ãé¡åŸ®é¡çèµ°æ»ã
ã³ã·ãã¡ããªãŒã§æ€åºããããšãã§ããäžã€ãã
ãã®é »åºŠããã³çšåºŠã¯ãèµ°æ»ããè¡šé¢ã®æ¯ãšããŠ
è¡šããããšãã§ããã
æ¬çºæã«ãããŠã¯ãèµ€è¡çã®å±€ã«å¯Ÿããå
ç«åž
çã«ããæäœã®çµåã¯ãå€ãã®éèŠãªå©ç¹ãæäŸ
ãããšããããšã«æ³šç®ãã¹ãã§ããã第äžã«ãé
åžžã®æ¶²çžè©Šéšã«å¯ŸããŠã¯äœãããæäœæ¿åºŠãæã
ãè¡æž ãæå¹ã«äœ¿çšããããšãã§ããããäœæ ãª
ãã°ããããã®ç¹ç°çãªæäœã®å«éããè¡çã®å
äžå±€äžã«çµåããæäœãšããŠãæ¿çž®ãããããšã
ã§ããããã§ããã第äºã«ãæªåžéã®è¡æž ããä»
ã®åŠšå®³è¡æž èçœè³ªã®ããã«ã液çžè©Šéšã«å¯ŸããŠã¯
䜿çšããããšãã§ããªãç°å¢äžã«ãè©Šéšãã¹ãæ
äœã®éžæçãªåžçããã³æŽæµã«ãã劚害èçœè³ªã®
é€å»ã«ãã€ãŠãããã劚害ããåºçžè©Šéšã«ãããŠ
ã¯åé¿ããããšãã§ããã第äžã«ãå€ãã®è¡æž
ã¯ãæãŸãããããç¹ç°æ§ãæããé€å»äžå¯èœãª
èçœè³ªãå«æããããã«ã液çžè©Šéšã«å¯ŸããŠã¯äœ¿
çšäžèœã§ãããæ¬çºæã«ãããŠã¯ã第äžã®å±€ã圢
æãã¹ãè¡çã®é©åœãªéžæã«ãã€ãŠãè©Šéšãã¹ã
æäœã®ã¿ãåžçãããããšãå¯èœã§ããã
çã«ããæäœã®çµåã¯ãå€ãã®éèŠãªå©ç¹ãæäŸ
ãããšããããšã«æ³šç®ãã¹ãã§ããã第äžã«ãé
åžžã®æ¶²çžè©Šéšã«å¯ŸããŠã¯äœãããæäœæ¿åºŠãæã
ãè¡æž ãæå¹ã«äœ¿çšããããšãã§ããããäœæ ãª
ãã°ããããã®ç¹ç°çãªæäœã®å«éããè¡çã®å
äžå±€äžã«çµåããæäœãšããŠãæ¿çž®ãããããšã
ã§ããããã§ããã第äºã«ãæªåžéã®è¡æž ããä»
ã®åŠšå®³è¡æž èçœè³ªã®ããã«ã液çžè©Šéšã«å¯ŸããŠã¯
䜿çšããããšãã§ããªãç°å¢äžã«ãè©Šéšãã¹ãæ
äœã®éžæçãªåžçããã³æŽæµã«ãã劚害èçœè³ªã®
é€å»ã«ãã€ãŠãããã劚害ããåºçžè©Šéšã«ãããŠ
ã¯åé¿ããããšãã§ããã第äžã«ãå€ãã®è¡æž
ã¯ãæãŸãããããç¹ç°æ§ãæããé€å»äžå¯èœãª
èçœè³ªãå«æããããã«ã液çžè©Šéšã«å¯ŸããŠã¯äœ¿
çšäžèœã§ãããæ¬çºæã«ãããŠã¯ã第äžã®å±€ã圢
æãã¹ãè¡çã®é©åœãªéžæã«ãã€ãŠãè©Šéšãã¹ã
æäœã®ã¿ãåžçãããããšãå¯èœã§ããã
æ¬çºæã¯çŽ°èã®åãŸãã¯çŽ°èã®é©åæ§ã®äœãã®
è©Šéšã«å¯ŸããŠãé©ããŠãããããšãã°ã现èåã®
å€å®ã®ããã«ã¯ãçµåããæäœãæãã第äžã®å±€
ãæ¢ç¥ã®åã®çŽ°èããã³æäœããæ§æããããã
æ£è ãŸãã¯äŸäžè ã®æªç¥ã®çŽ°èåã®å€å®ã¯ã第äº
ã®çŽ°èå±€ã圢æãã¹ããããã®èœåã«ãã€ãŠæ±ºå®
ããããšãã§ãããé©åæ§è©Šéšã®éè¡ã®ããã«
ã¯ãäŸäžè ã®çŽ°èãçšããŠç¬¬äžã®åäžå±€ã圢æã
ãã次ãã§ããããå ç«åžçã«ãã€ãŠçµåããã
ãšãå¯èœãªæ£è ã®è¡æž äžã®æäœãšåå¿ãããã°ã
ããç¶ãã®ã¡ãè£äœã®æ·»å åŸã®åŽ©å£ããŸãã¯çµå
ããæ£è ã®è¡æž äžã®æäœãïŒãããçµåãçãã
çšåºŠãŸã§ïŒåäžã®äŸäžè ã®çŽ°èãããäžåºŠäœçšã
ãããšãã«ãã®çŽ°èã®ç¬¬äºã®å±€ã圢æãã¹ãèœ
åãã®æž¬å®ã®äœããã«ãã€ãŠããããæ€åºããã
ãšãã§ããã
è©Šéšã«å¯ŸããŠãé©ããŠãããããšãã°ã现èåã®
å€å®ã®ããã«ã¯ãçµåããæäœãæãã第äžã®å±€
ãæ¢ç¥ã®åã®çŽ°èããã³æäœããæ§æããããã
æ£è ãŸãã¯äŸäžè ã®æªç¥ã®çŽ°èåã®å€å®ã¯ã第äº
ã®çŽ°èå±€ã圢æãã¹ããããã®èœåã«ãã€ãŠæ±ºå®
ããããšãã§ãããé©åæ§è©Šéšã®éè¡ã®ããã«
ã¯ãäŸäžè ã®çŽ°èãçšããŠç¬¬äžã®åäžå±€ã圢æã
ãã次ãã§ããããå ç«åžçã«ãã€ãŠçµåããã
ãšãå¯èœãªæ£è ã®è¡æž äžã®æäœãšåå¿ãããã°ã
ããç¶ãã®ã¡ãè£äœã®æ·»å åŸã®åŽ©å£ããŸãã¯çµå
ããæ£è ã®è¡æž äžã®æäœãïŒãããçµåãçãã
çšåºŠãŸã§ïŒåäžã®äŸäžè ã®çŽ°èãããäžåºŠäœçšã
ãããšãã«ãã®çŽ°èã®ç¬¬äºã®å±€ã圢æãã¹ãèœ
åãã®æž¬å®ã®äœããã«ãã€ãŠããããæ€åºããã
ãšãã§ããã
æ¬çºæã«ããã䜿çšã«å¯ŸããŠé©ããæ€åºæ¹æ³
ã¯ããã®æè¡åéã®çç·Žè ã«ã¯æçœã§ããããèµ€
è¡çã¯ãããèªèº«ã®æšç€ºãããªãã¡ã415nmã«æ¥µ
倧åžåãæããçè²ããèçœè³ªïŒãã¢ã°ããã³ïŒ
ãå«æããŠãããããæ ãèµ€è¡çã®ååšãŸãã¯äž
åšã¯ãåèšã®ããã«å ·åããç¹ç°çã«æ€åºããã
ãšãã§ãããããããªãããææã«å¿ãããã®ä»
ã®æšç€ºæ¹æ³ãåæ§ã«å ·åãã䜿çšããããšãã§ã
ãããã®ãããªæ¹æ³ã¯æŸå°æ§æšç€ºïŒããšãã°ã
51Crã 125IïŒãçååŠçæ¹æ³ïŒããšãã°ãéžæã
ã现èå é µçŽ ïŒããŸãã¯ã±ã€å æ€åºïŒããšãã°ç
åãŸãã¯æ»æ» 现èã®äœãããåå®ããããã®åå
çæ¢éïŒã®äœ¿çšãå å«ããããããã®æ¹æ³ã®ãã¹
ãŠã容æã«åšæ©äœ¿çšåããããšãã§ããããæ ã
èªååããããšãã§ããããããã¯ãè¡æ¶²è²¯èµè¡
æž åŠãæ³å»åŠçè¡æ¶²è©Šéšãçµç¹åå€å®ããã³é©å
æ§ã«å¯Ÿãã茞è¡åããã³ç§»æ€åè©Šéšã«å¯ŸããŠãå
æ§ã«é©çšå¯èœã§ããã
ã¯ããã®æè¡åéã®çç·Žè ã«ã¯æçœã§ããããèµ€
è¡çã¯ãããèªèº«ã®æšç€ºãããªãã¡ã415nmã«æ¥µ
倧åžåãæããçè²ããèçœè³ªïŒãã¢ã°ããã³ïŒ
ãå«æããŠãããããæ ãèµ€è¡çã®ååšãŸãã¯äž
åšã¯ãåèšã®ããã«å ·åããç¹ç°çã«æ€åºããã
ãšãã§ãããããããªãããææã«å¿ãããã®ä»
ã®æšç€ºæ¹æ³ãåæ§ã«å ·åãã䜿çšããããšãã§ã
ãããã®ãããªæ¹æ³ã¯æŸå°æ§æšç€ºïŒããšãã°ã
51Crã 125IïŒãçååŠçæ¹æ³ïŒããšãã°ãéžæã
ã现èå é µçŽ ïŒããŸãã¯ã±ã€å æ€åºïŒããšãã°ç
åãŸãã¯æ»æ» 现èã®äœãããåå®ããããã®åå
çæ¢éïŒã®äœ¿çšãå å«ããããããã®æ¹æ³ã®ãã¹
ãŠã容æã«åšæ©äœ¿çšåããããšãã§ããããæ ã
èªååããããšãã§ããããããã¯ãè¡æ¶²è²¯èµè¡
æž åŠãæ³å»åŠçè¡æ¶²è©Šéšãçµç¹åå€å®ããã³é©å
æ§ã«å¯Ÿãã茞è¡åããã³ç§»æ€åè©Šéšã«å¯ŸããŠãå
æ§ã«é©çšå¯èœã§ããã
ãã®æè¡åéã«ãããŠå
¬ç¥ã®ããã«ãä»æ¥ã液
çžè©Šéšã«ãããŠå€æ°ã®æé ãçšããããŠãããã
ãããã¯åºçžè©Šéšã«ãããŠãåæ§ã«æå¹ã§ãããš
æãããããã®ãããªæé ã«ã¯ãåéãå¯èœãªã
ãããããšãç¥ãããŠããæ·»å å€ïŒããšãã°ã察
称ãŸãã¯é察称芪氎æ§ã³ãã€ãé¡ãèçœé µçŽ ãã€
ãªã³æ§æ¿åç©ãé«ååé»è§£è³ªãç·åŒµå€ãããã³PH
ã調ç¯ããããã®ç·©è¡å€ç³»ïŒã®äœ¿çšãå«ãŸããã
ãããã®å åã«ã€ããŠã¯ãããšãã°ããŒã¯ãã³ã
ã«ãã€ãŠãTransfusionã11ïŒ317ã1971ãã«èš
ãããŠããã
çžè©Šéšã«ãããŠå€æ°ã®æé ãçšããããŠãããã
ãããã¯åºçžè©Šéšã«ãããŠãåæ§ã«æå¹ã§ãããš
æãããããã®ãããªæé ã«ã¯ãåéãå¯èœãªã
ãããããšãç¥ãããŠããæ·»å å€ïŒããšãã°ã察
称ãŸãã¯é察称芪氎æ§ã³ãã€ãé¡ãèçœé µçŽ ãã€
ãªã³æ§æ¿åç©ãé«ååé»è§£è³ªãç·åŒµå€ãããã³PH
ã調ç¯ããããã®ç·©è¡å€ç³»ïŒã®äœ¿çšãå«ãŸããã
ãããã®å åã«ã€ããŠã¯ãããšãã°ããŒã¯ãã³ã
ã«ãã€ãŠãTransfusionã11ïŒ317ã1971ãã«èš
ãããŠããã
æ¬çºæã¯å
ç«ç¹ç°æ§çŽ°èåå¿ãå
å«ãããã®ä»
ã®åé¡ã«å¯ŸããŠãé©çšããããšãã§ãããšããã
ãšã«æ³šç®ãã¹ãã§ããããã®ãããªãã®ã®äžã€ã¯
现èã®IgGãIgMãIgAãIGDããã³IGEå ç«ã°ã
ããªã³ãããã³C3ãC4ãªãã³ã«ãã®ä»ã®è£äœæ
åãããã¯çµå掻æ§åçæç©ã«ãã被èŠã«å¯ŸããŠ
现èãè©äŸ¡ããããã®æã°ãããªã³è©Šéšã§ãã
ïŒRosenfieldããVoxâSang.ã26ïŒ289ã333ã
1974åç §ïŒãããäžã€ã®å¿çšã¯ãååããã³éå
åè¡çåéè©Šéšã®äž¡è ã®ãå®éçè©äŸ¡ã䌎ãªãã
åºçžè©Šéšã§ãããååè¡çåéè©Šéšã¯ãæäœæ¿åºŠ
ã®çŽæ¥åæã«å¯ŸããŠãäžã€ãŸãå ±ææåã«åºã¥ã
競äºçµåã«ããå¯æº¶æ§æåã®éæ¥åæã«å¯ŸããŠã
䜿çšããããšãã§ããïŒNusbachersãJ.
Immunol.ã108ïŒ893ã1972ïŒãéååè©Šéšã¯ãé
æ¥çã«å¯æº¶æ§æåã枬å®ããïŒCookãImmunol.
ãïŒïŒ74ã1965ããã³JujiãYokochiãJapan J.
Exptl.Med.ã39ïŒ615ã1969ïŒãããã«ãè¡çã
åºçžè©Šéšã«ããæäœäžä»åéãŸãã¯åŽ©å£ã«å¯Ÿãã
ãããã®æåæ§ã«ã€ããŠè©Šéšããããšãã§ããã®
ãšã¡ããã©åæ§ã«ã现èãåè«é¡ãèé¡ããã³çµ
ç¹ãŸãã¯çš®çããã®å¹é€ãã现èã©ã€ã³ããæ¬ç¹
èš±ã«èª¬æããåºçžè©Šéšã«ãã€ãŠããããã®è¡šé¢äž
ã®æåæåã«ã€ããŠåæããããšãã§ããããã
ããã¯ãåºçžè©Šéšã䜿çšããŠãæçµçã«ã¯ãåå
çæäœæ¿åºŠãæäœçµåã®ïŒ«å€ããã³ïŒ«å€ã®äžåäž
æ§ã®çšåºŠã«é¢é£ããåé¡ã解決ããããšãäºæž¬ã
ãŠããã
ã®åé¡ã«å¯ŸããŠãé©çšããããšãã§ãããšããã
ãšã«æ³šç®ãã¹ãã§ããããã®ãããªãã®ã®äžã€ã¯
现èã®IgGãIgMãIgAãIGDããã³IGEå ç«ã°ã
ããªã³ãããã³C3ãC4ãªãã³ã«ãã®ä»ã®è£äœæ
åãããã¯çµå掻æ§åçæç©ã«ãã被èŠã«å¯ŸããŠ
现èãè©äŸ¡ããããã®æã°ãããªã³è©Šéšã§ãã
ïŒRosenfieldããVoxâSang.ã26ïŒ289ã333ã
1974åç §ïŒãããäžã€ã®å¿çšã¯ãååããã³éå
åè¡çåéè©Šéšã®äž¡è ã®ãå®éçè©äŸ¡ã䌎ãªãã
åºçžè©Šéšã§ãããååè¡çåéè©Šéšã¯ãæäœæ¿åºŠ
ã®çŽæ¥åæã«å¯ŸããŠãäžã€ãŸãå ±ææåã«åºã¥ã
競äºçµåã«ããå¯æº¶æ§æåã®éæ¥åæã«å¯ŸããŠã
䜿çšããããšãã§ããïŒNusbachersãJ.
Immunol.ã108ïŒ893ã1972ïŒãéååè©Šéšã¯ãé
æ¥çã«å¯æº¶æ§æåã枬å®ããïŒCookãImmunol.
ãïŒïŒ74ã1965ããã³JujiãYokochiãJapan J.
Exptl.Med.ã39ïŒ615ã1969ïŒãããã«ãè¡çã
åºçžè©Šéšã«ããæäœäžä»åéãŸãã¯åŽ©å£ã«å¯Ÿãã
ãããã®æåæ§ã«ã€ããŠè©Šéšããããšãã§ããã®
ãšã¡ããã©åæ§ã«ã现èãåè«é¡ãèé¡ããã³çµ
ç¹ãŸãã¯çš®çããã®å¹é€ãã现èã©ã€ã³ããæ¬ç¹
èš±ã«èª¬æããåºçžè©Šéšã«ãã€ãŠããããã®è¡šé¢äž
ã®æåæåã«ã€ããŠåæããããšãã§ããããã
ããã¯ãåºçžè©Šéšã䜿çšããŠãæçµçã«ã¯ãåå
çæäœæ¿åºŠãæäœçµåã®ïŒ«å€ããã³ïŒ«å€ã®äžåäž
æ§ã®çšåºŠã«é¢é£ããåé¡ã解決ããããšãäºæž¬ã
ãŠããã
æ¬çºæã«ãããŠå©çšããåºç€ãšãªãååŠçåç
ã®å€ãã¯ããããŸã§ããªããå ¬ç¥ã§ããããšãèª
ãããããæ¬çºæã¯ãè¡çåå€å®ã®å¹æçãªéè¡
ã®ããããã³è¡çãªãã³ã«ãã®ä»ã®çŽ°èã®é©åæ§
è©Šéšã®ããã«ããããã®åçãåºçžçŽ°èåäžå±€ã®
æ§æã«é©çšããããšãã§ãããšããããšããåŸæ¥
èªããããŠããªãã€ããšããçç±ã§ãç¬ç¹ã®ãã®
ã§ããã
ã®å€ãã¯ããããŸã§ããªããå ¬ç¥ã§ããããšãèª
ãããããæ¬çºæã¯ãè¡çåå€å®ã®å¹æçãªéè¡
ã®ããããã³è¡çãªãã³ã«ãã®ä»ã®çŽ°èã®é©åæ§
è©Šéšã®ããã«ããããã®åçãåºçžçŽ°èåäžå±€ã®
æ§æã«é©çšããããšãã§ãããšããããšããåŸæ¥
èªããããŠããªãã€ããšããçç±ã§ãç¬ç¹ã®ãã®
ã§ããã
å®æœäŸ
以äžã¯æ¬çºæã®å®éã®å®æœäŸã§ããã
å®æœäŸ ïŒ
人éã®æâæã«ããå
ç«åŽ©å£ãâãã¢ã«ã³
ã³âããªã¹ãã¬ã³è©Šéšç®¡ã䜿çšããŠãããããã¯
0.2mlã®ç·ç¶çŽ å溶液ïŒ0.5mgïŒmlïŒãïŒåéäœçš
ããã次ãã§ãæŽæµåŸã«ã0.2mlã®ååé140000
ããªââãªãžã³HBr溶液ïŒ0.1mgïŒmlïŒãïŒå
éäœçšããããåã³æŽæµããã®ã¡ãA1åè¡çã®
0.9ïŒ NaCläžã«ãããïŒãïŒïŒ ïŒå®¹éïŒå®¹éïŒæž
æ¿æ¶²0.2mlãïŒåéäœçšããããããã¯ïŒÃ106ïŒ
cm2ã®å¯åºŠã§èµ€è¡çã®å¹³é¢åäžå±€ã®ä»çããããã
ãããããã®èµ€è¡çã¯ãå€ãã®æŽæµã«ããããã
ããäžã€åŒ·åãªäººéã®æâã®äœçšã«ããããã
ããä»çãããŸãŸã«ä¿ããããæâã®é©çšåŸ
ã«ã0.2mlã®è£äœãäœçšããããšãã¯ãä»çãã
èµ€è¡çã®ãã¢ã°ããã³ã解æŸãããäžã€èŠ³å¯ãã
ãå ç«åŽ©å£ã®çšåºŠããä¿æããããã¢ã°ããã³ãš
ããŠããŸãã¯åäžå±€ãæ§æãããããã«çšããè¡
çãæšç€ºããããã«çšãã 51Crã®åœ¢æ ã§ä¿æãŸ
ãã¯è§£æŸãããæŸå°èœãšããŠãã®ã©ã¡ããã§æž¬å®
å¯èœã§ãã€ããè£äœã®æšæºçãªæäžã«ãããŠãæ
âã®åŽ©å£å¯èœæ§ãå®éçã«æž¬å®ããããšãã§ã
ãããããã¯ãŸããæâã®æšæºçãªæäžã«ãã
ãŠã厩å£æ§è£äœããå šäœçãªæ»Žå®ã«ãã€ãŠãè£äœ
äœçšã®å€å žçãªæ¹æ³ïŒã¢ã«ã¢ããRPã䜿çšããŠ
ãPillemerãL.ããScienceã120ïŒ279ã1954ãïŒ
ã«ãã€ãŠããããã¯äº€ä»£ããããŒãžã³æ¹æ³ïŒäººã®
è¡æž ã®Mg++ã§ã¯ãªãCa++ããã¬ãŒãããããã«
EGTAã䜿çšããŠãæªçºè¡šã®èŠ³å¯ãïŒã«ãã€ãŠã
å®çŸ©ããã³æž¬å®ããããšãã§ããã
ã³âããªã¹ãã¬ã³è©Šéšç®¡ã䜿çšããŠãããããã¯
0.2mlã®ç·ç¶çŽ å溶液ïŒ0.5mgïŒmlïŒãïŒåéäœçš
ããã次ãã§ãæŽæµåŸã«ã0.2mlã®ååé140000
ããªââãªãžã³HBr溶液ïŒ0.1mgïŒmlïŒãïŒå
éäœçšããããåã³æŽæµããã®ã¡ãA1åè¡çã®
0.9ïŒ NaCläžã«ãããïŒãïŒïŒ ïŒå®¹éïŒå®¹éïŒæž
æ¿æ¶²0.2mlãïŒåéäœçšããããããã¯ïŒÃ106ïŒ
cm2ã®å¯åºŠã§èµ€è¡çã®å¹³é¢åäžå±€ã®ä»çããããã
ãããããã®èµ€è¡çã¯ãå€ãã®æŽæµã«ããããã
ããäžã€åŒ·åãªäººéã®æâã®äœçšã«ããããã
ããä»çãããŸãŸã«ä¿ããããæâã®é©çšåŸ
ã«ã0.2mlã®è£äœãäœçšããããšãã¯ãä»çãã
èµ€è¡çã®ãã¢ã°ããã³ã解æŸãããäžã€èŠ³å¯ãã
ãå ç«åŽ©å£ã®çšåºŠããä¿æããããã¢ã°ããã³ãš
ããŠããŸãã¯åäžå±€ãæ§æãããããã«çšããè¡
çãæšç€ºããããã«çšãã 51Crã®åœ¢æ ã§ä¿æãŸ
ãã¯è§£æŸãããæŸå°èœãšããŠãã®ã©ã¡ããã§æž¬å®
å¯èœã§ãã€ããè£äœã®æšæºçãªæäžã«ãããŠãæ
âã®åŽ©å£å¯èœæ§ãå®éçã«æž¬å®ããããšãã§ã
ãããããã¯ãŸããæâã®æšæºçãªæäžã«ãã
ãŠã厩å£æ§è£äœããå šäœçãªæ»Žå®ã«ãã€ãŠãè£äœ
äœçšã®å€å žçãªæ¹æ³ïŒã¢ã«ã¢ããRPã䜿çšããŠ
ãPillemerãL.ããScienceã120ïŒ279ã1954ãïŒ
ã«ãã€ãŠããããã¯äº€ä»£ããããŒãžã³æ¹æ³ïŒäººã®
è¡æž ã®Mg++ã§ã¯ãªãCa++ããã¬ãŒãããããã«
EGTAã䜿çšããŠãæªçºè¡šã®èŠ³å¯ãïŒã«ãã€ãŠã
å®çŸ©ããã³æž¬å®ããããšãã§ããã
å
ç«ïŒ¡âæ厩å£ã®ç 究ã«å¯Ÿãããããã®æ¹æ³
ã®äœãããéåžžã®æ¶²çžè©Šéšã«ãã€ãŠã¯æ床ããäž
ã€åçŸå¯èœã«éè¡ããããšã¯ã§ããªããIgMã
IgGããã³IgAæäœâã¯ããã¹ãŠããããŠå¹ç
çãªA1åè¡çã®åéçŽ ã§ãããäžã€åéã¯å ç«
厩å£ã«ãã€ãŠåŠšå®³ããããåºçžæ¹æ³ã«ãã€ãŠãæ
âã®åŽ©å£å¯èœæ§ã¯ã枬å®å¯èœã§ãã€ãã°ããã§
ãªãã液çžè©Šéšã«ãã€ãŠèå¥ã§ããããã50åã®
åžé床ã«ãããŠãæ€åºå¯èœã§ãããããæ ããã®
æ¹æ³ã®èšºæã«åœ¹ç«ã¡ããå¯èœæ§ã¯ãããããŠå€§ã
ãã
ã®äœãããéåžžã®æ¶²çžè©Šéšã«ãã€ãŠã¯æ床ããäž
ã€åçŸå¯èœã«éè¡ããããšã¯ã§ããªããIgMã
IgGããã³IgAæäœâã¯ããã¹ãŠããããŠå¹ç
çãªA1åè¡çã®åéçŽ ã§ãããäžã€åéã¯å ç«
厩å£ã«ãã€ãŠåŠšå®³ããããåºçžæ¹æ³ã«ãã€ãŠãæ
âã®åŽ©å£å¯èœæ§ã¯ã枬å®å¯èœã§ãã€ãã°ããã§
ãªãã液çžè©Šéšã«ãã€ãŠèå¥ã§ããããã50åã®
åžé床ã«ãããŠãæ€åºå¯èœã§ãããããæ ããã®
æ¹æ³ã®èšºæã«åœ¹ç«ã¡ããå¯èœæ§ã¯ãããããŠå€§ã
ãã
å®æœäŸ ïŒ
è¡æ¶²åå€å® 人éã®èµ€è¡çã®åãå€å®ãäžã€èŒž
è¡åã®é©åæ§è©Šéšã®æç¹ã«ãããŠäººéã®æèµ€è¡ç
æäœãæ€åºããã«ã€ããŠã®åé¡ã¯ãç¡èŠã§ããªã
ãã®ããããå®éã«ãçŽæ¥çãªåéã«ããããã
ã€ãã®èµ€è¡çè¡æ¶²åèå¥ã®å¯äžã®æ段ã¯ãé«äŸ¡äž
ã€è€éãªæ©åšã®äœ¿çšãèŠããïŒBerkmanãE.ã
M.ãããTransfusionã11ïŒ317ã1971ïŒãããã
ãªãããæ©åšã«ãã液çžæ¹æ³ãåºçžè©Šéšã«å¯ŸããŠ
é©çšããããããã§ããããã¯ãRhãã±ã«ãã
ããããããã€ãŒãXgaãã«ã€ã¹ãã©ã»ã©ã³ãã
ã³MNSsã«å¯Ÿããç¹ç°çãªåã®èå¥ã®éè¡ã«ãã
ãŠããã¹ãŠäžèšã®æ©åšäœ¿çšã«ãã液çžè©Šéšã«ãã€
ãŠåŸããããã®ãè¶ ããæ床ã«ãããŠæåããã
è¡æ¶²åã®å€å®ã«å¯ŸããŠã¯ãèµ€è¡çã®åäžå±€ããå
ç«åŽ©å£ã«å¯ŸããŠå®æœäŸïŒã«èšããããã«ããŠãæ§
æãããããããããªããããã®å Žåã¯ããã®å
äžå±€ããå ãæ¢ç¥ã®ç¹ç°æ§ã®æäœïŒ0.2mlïŒã«æŽ
ãã次ãã§èžçæ°Žã«ãã€ãŠäœåŒµçã«åŽ©å£ãããã
ãã®æç¹ã«ãããŠã0.2ïŒ ïŒå®¹éïŒå®¹éïŒã®æ¿åºŠ
ã®èµ€è¡ç0.1mlã®ç¬¬äºã®é©çšãäžããŠã軜ã第äº
ã®åäžå±€ãšããŠæ²éããããããã§ããããããª
æ¹æ³ã«ãã€ãŠããã®ç¬¬äºã®åäžå±€ã®ç¹ç°æ§æäœçµ
åãä¿é²ããããããšãå¯èœã§ãã€ããããšã
ã°ãããŒã¯ãã³ãã®äœã€ãªã³æ¹æ³ã¯ãå ãäžæŸæ¶²
ãïŒïŒ ã®ãã³ãããŒã«ããã³0.0025ïŒ ã®ããã¿ã
ã³ç¡«é žå¡©ã®PH6.0ã®æº¶æ¶²ã«ãã€ãŠçœ®æãã次ã
ã§ã宀枩ã«ãããŠïŒåã®åŸã«ã第äºã®åäžå±€ã
0.0014Mãªã³é žå¡©ã§ç·©è¡ãããPH7.3ã®0.85ïŒ
NaClã«ãã€ãŠæŽæµããããšã«ãã€ãŠãæå¹ã«äœ¿
çšããããããã¯æäœã®çµåããªãæ¢ç¥ã®é°æ§ã®
è¡çãé€å»ããããæäœã®çµåããæ¢ç¥ã®éœæ§ã®
è¡çã¯é€å»ããªãã€ãããããè¡çã®æäœçµåã
å¢é²ããããã®ä»ã®æ¹æ³ã®ã»ãããããã«æå©ã§
ããããšãèªããããäžã€ãããã®äžã®ããã€ã
ã¯ãããŒã¯ãã³ã®æ¶²çžæ©åšäœ¿çšæ¹æ³ã«ãã€ãŠã¯æ
å¹ã«äœ¿çšã§ããªããã®ã§ãã€ããããããŠããã
ããã¯ãäžæŸæ¶²ãæåã«2.5ïŒ ã®PVPãå«æãã
PH7.0ã®ç·©è¡æ¶²ã«ãã€ãŠã次ãã§0.01ïŒ ã®ç¡«é žã
ãã¿ãã³ãå«æããPH6.0ã®åæ§ãªç·©è¡å€ã«ãã€
ãŠãé 次ã«çœ®æããããšã«ãã€ãŠã第äºã®åäžå±€
ã®ç¹ç°çæäœã®çµåãä¿é²ããããããã®è©Šéšç©
ããæåŸã«PH7.3ã®0.2Mãªã³é žå¡©ç·©è¡å€ã«ãã€ãŠ
æŽæµãããæããã«ãåºçžåéè©Šéšã®ä¿é²ã®ãã
ã®å¯èœæ§ã¯ããã®è©Šéšæ¹æ³ã¯æ¶²çžè©Šéšã«äŒŽãªãå€
ãã®åé¡ãåé¿ãããæ ã«ãå€ãååšããã
è¡åã®é©åæ§è©Šéšã®æç¹ã«ãããŠäººéã®æèµ€è¡ç
æäœãæ€åºããã«ã€ããŠã®åé¡ã¯ãç¡èŠã§ããªã
ãã®ããããå®éã«ãçŽæ¥çãªåéã«ããããã
ã€ãã®èµ€è¡çè¡æ¶²åèå¥ã®å¯äžã®æ段ã¯ãé«äŸ¡äž
ã€è€éãªæ©åšã®äœ¿çšãèŠããïŒBerkmanãE.ã
M.ãããTransfusionã11ïŒ317ã1971ïŒãããã
ãªãããæ©åšã«ãã液çžæ¹æ³ãåºçžè©Šéšã«å¯ŸããŠ
é©çšããããããã§ããããã¯ãRhãã±ã«ãã
ããããããã€ãŒãXgaãã«ã€ã¹ãã©ã»ã©ã³ãã
ã³MNSsã«å¯Ÿããç¹ç°çãªåã®èå¥ã®éè¡ã«ãã
ãŠããã¹ãŠäžèšã®æ©åšäœ¿çšã«ãã液çžè©Šéšã«ãã€
ãŠåŸããããã®ãè¶ ããæ床ã«ãããŠæåããã
è¡æ¶²åã®å€å®ã«å¯ŸããŠã¯ãèµ€è¡çã®åäžå±€ããå
ç«åŽ©å£ã«å¯ŸããŠå®æœäŸïŒã«èšããããã«ããŠãæ§
æãããããããããªããããã®å Žåã¯ããã®å
äžå±€ããå ãæ¢ç¥ã®ç¹ç°æ§ã®æäœïŒ0.2mlïŒã«æŽ
ãã次ãã§èžçæ°Žã«ãã€ãŠäœåŒµçã«åŽ©å£ãããã
ãã®æç¹ã«ãããŠã0.2ïŒ ïŒå®¹éïŒå®¹éïŒã®æ¿åºŠ
ã®èµ€è¡ç0.1mlã®ç¬¬äºã®é©çšãäžããŠã軜ã第äº
ã®åäžå±€ãšããŠæ²éããããããã§ããããããª
æ¹æ³ã«ãã€ãŠããã®ç¬¬äºã®åäžå±€ã®ç¹ç°æ§æäœçµ
åãä¿é²ããããããšãå¯èœã§ãã€ããããšã
ã°ãããŒã¯ãã³ãã®äœã€ãªã³æ¹æ³ã¯ãå ãäžæŸæ¶²
ãïŒïŒ ã®ãã³ãããŒã«ããã³0.0025ïŒ ã®ããã¿ã
ã³ç¡«é žå¡©ã®PH6.0ã®æº¶æ¶²ã«ãã€ãŠçœ®æãã次ã
ã§ã宀枩ã«ãããŠïŒåã®åŸã«ã第äºã®åäžå±€ã
0.0014Mãªã³é žå¡©ã§ç·©è¡ãããPH7.3ã®0.85ïŒ
NaClã«ãã€ãŠæŽæµããããšã«ãã€ãŠãæå¹ã«äœ¿
çšããããããã¯æäœã®çµåããªãæ¢ç¥ã®é°æ§ã®
è¡çãé€å»ããããæäœã®çµåããæ¢ç¥ã®éœæ§ã®
è¡çã¯é€å»ããªãã€ãããããè¡çã®æäœçµåã
å¢é²ããããã®ä»ã®æ¹æ³ã®ã»ãããããã«æå©ã§
ããããšãèªããããäžã€ãããã®äžã®ããã€ã
ã¯ãããŒã¯ãã³ã®æ¶²çžæ©åšäœ¿çšæ¹æ³ã«ãã€ãŠã¯æ
å¹ã«äœ¿çšã§ããªããã®ã§ãã€ããããããŠããã
ããã¯ãäžæŸæ¶²ãæåã«2.5ïŒ ã®PVPãå«æãã
PH7.0ã®ç·©è¡æ¶²ã«ãã€ãŠã次ãã§0.01ïŒ ã®ç¡«é žã
ãã¿ãã³ãå«æããPH6.0ã®åæ§ãªç·©è¡å€ã«ãã€
ãŠãé 次ã«çœ®æããããšã«ãã€ãŠã第äºã®åäžå±€
ã®ç¹ç°çæäœã®çµåãä¿é²ããããããã®è©Šéšç©
ããæåŸã«PH7.3ã®0.2Mãªã³é žå¡©ç·©è¡å€ã«ãã€ãŠ
æŽæµãããæããã«ãåºçžåéè©Šéšã®ä¿é²ã®ãã
ã®å¯èœæ§ã¯ããã®è©Šéšæ¹æ³ã¯æ¶²çžè©Šéšã«äŒŽãªãå€
ãã®åé¡ãåé¿ãããæ ã«ãå€ãååšããã
ãããã®åºçžè©Šéšã¯ãIgGRhæäœã®æ€åºã«å¯Ÿã
ãŠããããŠææã§ããããšãèªããããŠãããã
ãããã¯ãä¿é²ãªãŒãã¢ãã©ã€ã¶ãŒåæã«å¯ŸããŠ
å ã«èšãããã®ãšã»ãŒåäžã®ãèµ€è¡çåœãã®æäœ
ååã«å¯Ÿããæ床ãããªãã¡ã50ïŒ è¡çåéã«ã
ããè¡çåœãã10æäœååïŒRosenfieldããAnn.
N.Y.Acad.Sci.ã190ïŒ519ã1971ïŒãšããæ床ã
ãéæãããããããªããåºçžè©Šéšã«ãããŠã¯ã
ããããã¯1/1000å°ãªãèµ€è¡çã䜿çšãäžã€1000
åã®äœæ¥æ床ããã€ãŠãçŽ1pgæäœèçœè³ªïŒmlã
æ€åºããããããã¯çäœå 现èçåã«å¯Ÿããè©Šéš
ãå å«ããæ¢è¿°ã®äœãã®è©Šéšã®æ床ãããã®ãã§
ããã
ãŠããããŠææã§ããããšãèªããããŠãããã
ãããã¯ãä¿é²ãªãŒãã¢ãã©ã€ã¶ãŒåæã«å¯ŸããŠ
å ã«èšãããã®ãšã»ãŒåäžã®ãèµ€è¡çåœãã®æäœ
ååã«å¯Ÿããæ床ãããªãã¡ã50ïŒ è¡çåéã«ã
ããè¡çåœãã10æäœååïŒRosenfieldããAnn.
N.Y.Acad.Sci.ã190ïŒ519ã1971ïŒãšããæ床ã
ãéæãããããããªããåºçžè©Šéšã«ãããŠã¯ã
ããããã¯1/1000å°ãªãèµ€è¡çã䜿çšãäžã€1000
åã®äœæ¥æ床ããã€ãŠãçŽ1pgæäœèçœè³ªïŒmlã
æ€åºããããããã¯çäœå 现èçåã«å¯Ÿããè©Šéš
ãå å«ããæ¢è¿°ã®äœãã®è©Šéšã®æ床ãããã®ãã§
ããã
èçœé
µçŽ åŠçããèµ€è¡çãçšããŠãæâRhã«
ããè©ŠéšããŸããæå¹ã«è¡ãªããããå¹³åºã®ãã¯
ã滎å®ããªã¹ãã¬ã³ç¿äžã§è¡ãªã€ãŠãããè©Šéš
ã¯ãç¹ç°çã«ä»çããèµ€è¡çã®é¡åŸ®é¡çæ€æ»ãå¯
èœãšãããçµåããè¡çã¯ãããããRhâéœæ§
ã§ããå Žåã«ã®ã¿ååšãäžã€Rhâéœæ§ããã³Rh
âé°æ§èµ€è¡çã®äººå·¥æ··åç©ã®è©Šéšã«ãããŠã¯ãä»
çããªãè¡çããã®âç©Žâãã人工混åç©äžã®
Rhâé°æ§è¡çã®å²åã«å¯Ÿå¿ããé¢ç©ã§èªããã
ãããã®çµæã¯ãæ¬çºæã«ããè¡æ¶²è©Šæäžã®éçµ
åè¡çã®å²åãå®éçã«ç¢ºãããããšãã§ããã
ãšã瀺ããŠããããããã¯ã¢ãã·ãŠããŒæ³
ïŒArch.Int.Med.ã35ïŒ516ã1925ïŒã«ãã茞è¡ã
ãè¡çã®çåã®è©äŸ¡åæã«ãããŠãäžã€äººéã®ã
ã¡ã©ã®ç¹æ§ææïŒRaceããã³Sangerãâ人éã«ã
ããè¡æ¶²çŸ€âãDavisã1968ã475ã490é ïŒã«ã
ããŠãã®äž¡æ¹ã§ãããããŠéèŠãªåé¡ã§ããã
ããè©ŠéšããŸããæå¹ã«è¡ãªããããå¹³åºã®ãã¯
ã滎å®ããªã¹ãã¬ã³ç¿äžã§è¡ãªã€ãŠãããè©Šéš
ã¯ãç¹ç°çã«ä»çããèµ€è¡çã®é¡åŸ®é¡çæ€æ»ãå¯
èœãšãããçµåããè¡çã¯ãããããRhâéœæ§
ã§ããå Žåã«ã®ã¿ååšãäžã€Rhâéœæ§ããã³Rh
âé°æ§èµ€è¡çã®äººå·¥æ··åç©ã®è©Šéšã«ãããŠã¯ãä»
çããªãè¡çããã®âç©Žâãã人工混åç©äžã®
Rhâé°æ§è¡çã®å²åã«å¯Ÿå¿ããé¢ç©ã§èªããã
ãããã®çµæã¯ãæ¬çºæã«ããè¡æ¶²è©Šæäžã®éçµ
åè¡çã®å²åãå®éçã«ç¢ºãããããšãã§ããã
ãšã瀺ããŠããããããã¯ã¢ãã·ãŠããŒæ³
ïŒArch.Int.Med.ã35ïŒ516ã1925ïŒã«ãã茞è¡ã
ãè¡çã®çåã®è©äŸ¡åæã«ãããŠãäžã€äººéã®ã
ã¡ã©ã®ç¹æ§ææïŒRaceããã³Sangerãâ人éã«ã
ããè¡æ¶²çŸ€âãDavisã1968ã475ã490é ïŒã«ã
ããŠãã®äž¡æ¹ã§ãããããŠéèŠãªåé¡ã§ããã
å®æœäŸ ïŒ
çŽæ¥çæã°ãããªã³è©Šéšããããã®è©Šéšã¯ãåŸ
倩æ§æº¶è¡æ§è²§è¡ã®çããæããæ£è ããã®æŽæµã
ãèµ€è¡çãçšããŠç¬¬äžããã³ç¬¬äºã®è¡çåäžå±€ã
æ§æãããã以å€ã¯ãè¡æ¶²å€å®è©Šéšãšåæ§ã«è¡ãª
ã€ãã第äžã®åäžå±€ïŒããªãªãžã³ç·ç¶çŽ åã«ãã€
ãŠçµåïŒããåç¬ã®ç°åžžçºçæâ人ã°ãããªã³è¡
æž ã«ããããã®ã¡ãïŒç¹ç°æ§ãè©äŸ¡ãããããã
ã®è¡æž ã¯ãããããIgGãIgMãIgAãIgDã
IgEãC3ããã³C4ã«å¯ŸããŠç¹ç°æ§ã§ãã€ããæ
äœè¢«èŠãã第äžã®åäžå±€ãã次ãã§äœåŒµçã«åŽ©å£
ããäžã€æŽæµããã®ã¡ã第äºã®åäžå±€ã®ããã®è¡
çãäœçšãããã第äºã®åäžå±€ã®çµåã¯ã0.9ïŒ
ã®NaCläžã®ïŒïŒ â90ããªããã«ãããªãã³
ïŒPVPãå¹³åååé300000ïŒãæ·»å ããããšã«ã
ã€ãŠä¿é²ããã第äºã®åäžå±€ããæåŸã«åãªã
0.9ïŒ NaClã«ãã€ãŠæŽæµããããã®æ¹æ³ã¯ãã¹ãŒ
ãïŒHsu et al.ãVox Sang.ã26ïŒ305ïŒ1974ïŒ
ãèšããŠããæ¹æ³ãšè¿äŒŒããŠããããåºçžã«ãã
éœæ§ã®çµæã¯ãã¹ãŒã®æ¶²çžæ©åšäœ¿çšè©Šéšã®ãã®ã
ããèããããããŠãããPVPäžã«ããã匷ãèª
ç¶æ¶²çžåéã®ããã«ä»çæ§èçœè³ªã«å¯ŸããŠåã®å€
å®ãã§ããªãã€ãã掻æ§ã®åŸå€©ç溶è¡æ§è²§è¡ãæ
ããæ£è ã¯ãIgGãIgMãIgAãIgEãC3ããã³
C4ã«å¯ŸããŠæããã«éœæ§ã§ããããšãèªããã
ãã
倩æ§æº¶è¡æ§è²§è¡ã®çããæããæ£è ããã®æŽæµã
ãèµ€è¡çãçšããŠç¬¬äžããã³ç¬¬äºã®è¡çåäžå±€ã
æ§æãããã以å€ã¯ãè¡æ¶²å€å®è©Šéšãšåæ§ã«è¡ãª
ã€ãã第äžã®åäžå±€ïŒããªãªãžã³ç·ç¶çŽ åã«ãã€
ãŠçµåïŒããåç¬ã®ç°åžžçºçæâ人ã°ãããªã³è¡
æž ã«ããããã®ã¡ãïŒç¹ç°æ§ãè©äŸ¡ãããããã
ã®è¡æž ã¯ãããããIgGãIgMãIgAãIgDã
IgEãC3ããã³C4ã«å¯ŸããŠç¹ç°æ§ã§ãã€ããæ
äœè¢«èŠãã第äžã®åäžå±€ãã次ãã§äœåŒµçã«åŽ©å£
ããäžã€æŽæµããã®ã¡ã第äºã®åäžå±€ã®ããã®è¡
çãäœçšãããã第äºã®åäžå±€ã®çµåã¯ã0.9ïŒ
ã®NaCläžã®ïŒïŒ â90ããªããã«ãããªãã³
ïŒPVPãå¹³åååé300000ïŒãæ·»å ããããšã«ã
ã€ãŠä¿é²ããã第äºã®åäžå±€ããæåŸã«åãªã
0.9ïŒ NaClã«ãã€ãŠæŽæµããããã®æ¹æ³ã¯ãã¹ãŒ
ãïŒHsu et al.ãVox Sang.ã26ïŒ305ïŒ1974ïŒ
ãèšããŠããæ¹æ³ãšè¿äŒŒããŠããããåºçžã«ãã
éœæ§ã®çµæã¯ãã¹ãŒã®æ¶²çžæ©åšäœ¿çšè©Šéšã®ãã®ã
ããèããããããŠãããPVPäžã«ããã匷ãèª
ç¶æ¶²çžåéã®ããã«ä»çæ§èçœè³ªã«å¯ŸããŠåã®å€
å®ãã§ããªãã€ãã掻æ§ã®åŸå€©ç溶è¡æ§è²§è¡ãæ
ããæ£è ã¯ãIgGãIgMãIgAãIgEãC3ããã³
C4ã«å¯ŸããŠæããã«éœæ§ã§ããããšãèªããã
ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ (a) åºäœåºè³ªã«å¯ŸããŠéå¯éçã«çµåãã现
èã該现èã¯ãã®äžã«å 倩æ§ãããã¯åŸå€©æ§æ
åãæãããã®ç¬¬äžã®åäžå±€ã圢æãããïŒ (b) 該局(a)ãæäœå«æ溶液ãšæ¥è§ŠããããŠã該溶
液ã®æäœãäžèšç¬¬äžã®å±€ã®çŽ°èã®æåãšåå¿æ§
ã§ããçšåºŠãŸã§ãæäœã®å±€ãå ç«åžçã«ããçµ
åããïŒ (c) ç¶ãã®ã¡ããã®äžã«æåãæãã第äºã®çŽ°è
ã®æžæ¿æ¶²ãäœçšãããïŒäžã€ (d) ã€ãã§ã现èã®äžèšç¬¬äžã®å±€ã«çµåããæäœ
ã«ãã€ãŠã該第äºã®çŽ°èã®å ç«ä»çã®çšåºŠã枬
å®ãã 段éããæãããšãç¹åŸŽãšãããåºäœåºè³ªäžã«ã
ãã现èåãããã¯é©åæ§åææ¹æ³ã ïŒ çŽ°èã®è©²ç¬¬äžã®å±€åã³è©²ç¬¬äºã®çŽ°èã第äžã®
å人ã®çŽ°èã§ãã€ãŠãäžã€è©²æº¶æ¶²ã第äºã®å人ã
ãåŸãããè¡æž ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®æ¹æ³ã ïŒ å±€(c)ããè©Šéšãã¹ã现èæ¯éå£ããã®çŽ°è
ããåäžå±€ã圢æããã®ã«æ¬è³ªçã«ã¡ããã©å å
ãªæ°ã§äœçšããããããšã«ãã圢æããããããŠ
該åäžå±€ã®å ç«ä»çã®çšåºŠãç¹å®ã®æåãæ æã
ãŠããè©Šéšãã现èã®çŸåçã®é¢æ°ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ è©²æäœå«æ溶液ãã(i)該局(a)ã®çŽ°èã«ããæ
æãããæåãšå ç«åžçã«ããåå¿ããæäœã®æº¶
液åã³(ii)該溶液(i)äžã®æäœã®æå¶ã«ãã€ãŠæåç
決å®èŠçŽ ãåæãããã¹ã第äºã®æº¶æ¶²ãããã¯æž
æ¿æ¶²ãšã®æ··åç©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®æ¹æ³ã ïŒ è©²ç¬¬äžã®çŽ°èå±€(a)ã®æåãã該现èæ¯éå£ã®
è¡šé¢äžã«çµåããå ç«ã°ãããªã³ãããã¯è£äœæ
åã«ããæ æãããæåã§ããïŒæ®µé(b)ã§çšãã
該溶液äžã®æäœãã該第äžã®çŽ°è第äžå±€äžã®åæ
ãã¹ãå ç«ã°ãããªã³ãããã¯è£äœæåã«ããæ
æãããæåç決å®èŠçŽ ã«å¯Ÿããæâå ç«ã°ãã
ãªã³ãããã¯æâè£äœã§ããïŒãããŠè©²ç¬¬äºã®å±€
ã®çŽ°èãã段é(b)ã§çšãã該æäœã«å ç«ä»çãã
æåç決å®èŠçŽ ãæ æããŠããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®æ¹æ³ã ïŒ è©²å ç«ã°ãããªã³ãããã¯è£äœæåãã該局
(a)ãæ§æãããåŸã«è©²çŽ°èå±€(a)ã®çŽ°èã«çµåãã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ®µé(a)ã«ãããŠçµåããã該现èããåæã
ã¹ãå ç«ã°ãããªã³ãããã¯è£äœæåãæ æããŠ
ãããæã¯ããããæ æããããã«æäœãããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ (a) åºäœåºè³ªã«å¯ŸããŠéå¯éçã«çµåããèµ€
è¡çã該赀è¡çã¯ãã®äžã«å 倩æ§ãããã¯åŸå€©
æ§æåãæãããã®ç¬¬äžã®åäžå±€ã圢æãã
ãïŒ (b) 該局(a)ãæäœå«æ溶液ãšæ¥è§ŠããããŠã該溶
液ã®æäœãäžèšç¬¬äžã®å±€ã®èµ€è¡çã®æåãšåå¿
æ§ã§ããçšåºŠãŸã§ãæäœã®å±€ãå ç«åžçã«ãã
çµåããïŒ (c) ç¶ãã®ã¡ããã®äžã«æåãæãã第äºã®èµ€è¡
çã®æžæ¿æ¶²ãäœçšãããïŒäžã€ (d) ã€ãã§ãèµ€è¡çã®äžèšç¬¬äžã®å±€ã«çµåããæ
äœã«ãã€ãŠã該第äºã®èµ€è¡çã®å ç«ä»çã®çšåºŠ
ã枬å®ãã 段éããæãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®åºäœåºè³ªäžã«ããã现èåãããã¯é©
åæ§åææ¹æ³ã ïŒ è©²ç¬¬äºã®èµ€è¡çãäœçšããããã«å ç«ã€ãŠã
該赀è¡çã®ç¬¬äžã®å±€ã厩å£ãããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該溶液(b)ãäœçšãããåŸã«ã該第äžã®å±€ã®
èµ€è¡çã厩å£ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
æ¹æ³ã ïŒïŒ èµ€è¡çã®è©²ç¬¬äžã®å±€åã³è©²ç¬¬äºã®èµ€è¡çã
第äžã®å人ã®èµ€è¡çã§ãã€ãŠãäžã€è©²æº¶æ¶²ã第äº
ã®å人ããåŸãããè¡æž ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®æ¹æ³ã ïŒïŒ å±€(c)ããè©Šéšãã¹ãèµ€è¡çæ¯éå£ããã®çŽ°
èããåäžå±€ã圢æããã®ã«æ¬è³ªçã«ã¡ããã©å
åãªæ°ã§äœçšããããããšã«ãã圢æããããã
ãŠè©²ç¬¬äºã®åäžå±€ã®å ç«ä»çã®çšåºŠãç¹å®ã®æå
ãæ æããŠããè©Šéšããèµ€è¡çã®çŸåçã®é¢æ°ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該æäœå«æ溶液ãã(i)該局(a)ã®èµ€è¡çã«ã
ãæ æãããæåãšå ç«åžçã«ããåå¿ããæäœ
ã®æº¶æ¶²åã³(ii)該溶液(i)äžã®æäœã®æå¶ã«ãã€ãŠæ
åç決å®èŠçŽ ãåæãããã¹ã第äºã®æº¶æ¶²ããã
ã¯æžæ¿æ¶²ãšã®æ··åç©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®æ¹æ³ã ïŒïŒ 該第äžã®èµ€è¡çå±€ã®æåãã該赀è¡çæ¯é
å£ã®è¡šé¢äžã«çµåããå ç«ã°ãããªã³ãããã¯è£
äœæåã«ããæ æãããæåã§ããïŒæ®µé(b)ã§çš
ãã該溶液äžã®æäœãã該第äžã®èµ€è¡çåäžå±€äž
ã®åæãã¹ãæäœãããã¯è£äœã«ããæ æããã
æåç決å®èŠçŽ ã«äœããæâå ç«ã°ãããªã³ãã
ãã¯æâè£äœã§ããïŒãããŠè©²ç¬¬äºã®å±€ã®èµ€è¡ç
ãã段é(b)ã§çšãã該æäœã«å ç«ä»çããæåç
決å®èŠçŽ ãæ æããŠããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®æ¹æ³ã ïŒïŒ 該å ç«ã°ãããªã³ãããã¯è£äœæåãã該
å±€(a)ãæ§æãããåŸã«è©²å±€(a)ã®èµ€è¡çã«çµåãã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該赀è¡çã®åäžå±€(a)ãã被èŠãããã¹ã該
åºäœåºè³ªã«è©²èµ€è¡çã®æžæ¿æ¶²ãäœçšãããããšã«
ãã圢æããã該åºäœåºè³ªã®è¡šé¢ã«ã¯è©²èµ€è¡çã
該åºè³ªã«é£çµããã®ã«æå¹ãªåå¿æ§ã®ååŠåºãå
åšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該åå¿æ§ã®ååŠåºããããªã¹ãã¬ã³åºäœåº
質ããã€ããªããŒã²ã³æº¶æ¶²åã³ããªãªãžã³æº¶æ¶²
ã§ã該åºè³ªã®è¡šé¢ã«è©²åå¿æ§ã®ååŠåºã圢æãã
ã®ã«æå¹ãªæ¡ä»¶äžã«ãé 次åŠçããããšã«ãã圢
æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 现è矀ïŒcell cohortïŒã«æ æãããŠããŠã
ããè¿œå ã®æåã®ããã®æ¢ç¥æåãæ æãã现è
矀ã該现è矀ã¯è©²æ¢ç¥æåãæ¬ åŠããå°ãªããšã
ä»ã®çŽ°è矀ãå«æãã现èè©Šæäžã®ãã®ã§ããã
ã®åå€å®æ¹æ³ã§ãã€ãŠã (a) åºäœåºè³ªã«å¯ŸããŠéå¯éçã«çµåãã现èã®
第äžã®åäžå±€ã該现èã®ç¬¬äžã®åäžå±€ã¯åäžçŽ°
èæ¯éå£ããã®ãã®ã§ããäžã€äžèšæ¢ç¥æåã
æ æããŠãããã圢æããããïŒ (b) 該局(a)ã該æåã«å¯Ÿããæäœå«æ溶液ãšæ¥è§Š
ããããŠã該现èã®å±€(a)ã«å ç«åžçã«ããçµå
ããæäœã®å±€ã圢æãïŒ (c) å ç«ä»çã«ããæ¢ç¥æåãæ æãã矀现è
ïŒcohort cellsïŒã®å®å šãªç¬¬äºã®åäžå±€ã圢æã
ãã®ã«æå¹ãªæ¡ä»¶äžã«ã該现èè©Šæãäœçšãã
ãïŒ (d) 該第äžã®çŽ°èæ¯éå£ã«åºããŠåæãã¹ã該远
å ã®æåã«å¯Ÿããæäœã§ãã第äºã®æäœå«æ溶
液ãäœçšãããïŒ (e) åæãã¹ãæåãæ æããããšãæ¢ç¥ã®çŽ°è
ã®æžæ¿æ¶²ãäœçšãããïŒäžã€ (f) ã€ãã§ã现èã®è©²ç¬¬äžã®å±€ã®å ç«ä»çã®çšåºŠ
ã枬å®ãã 段éãããªãããšãç¹åŸŽãšããäžèšçŽ°è矀ã®åå€
å®æ¹æ³ã ïŒïŒ (a) åºäœåºè³ªã«å¯ŸããŠéå¯éçã«çµåãã
æŽæµèµ€è¡çã該赀è¡çã¯ãã®äžã«å 倩æ§ããã
ã¯åŸå€©æ§æåãæãããã®ç¬¬äžã®åäžå±€ã圢æ
ãããïŒ (b) 該局(a)ãæäœå«æ溶液ãšäœæžããã€ãªã³æ¿åºŠ
æ¡ä»¶äžã«æ¥è§ŠããããŠã該溶液ã®æäœãäžèšç¬¬
äžã®å±€ã®èµ€è¡çã®æåãšåå¿æ§ã§ããçšåºŠãŸ
ã§ãèµ€è¡çã®è©²ç¬¬äžã®åäžå±€ã«æäœã®å±€ãå ç«
åžçã«ããçµåããïŒ (c) ç¶ãã®ã¡ããã®äžã«æåãæãã第äºã®èµ€è¡
çã®æžæ¿æ¶²ãäœçšãããããããŠèµ€è¡çã®è©²ç¬¬
äžã®å±€ãèŠã第äºã®åäžå±€ãšããŠè©²ç¬¬äºã®èµ€è¡
çã該åºäœåºè³ªäžã«æ²æŸ±ããã®ã蚱容ãïŒ (d) 該第äºã®åäžå±€ã圢æãããåŸã該第äžã®å
äžå±€ã«çµåããæäœã«å¯Ÿããäžèšç¬¬äºã®èµ€è¡ç
ã®å ç«åžçãä¿é²ããã®ã«å åãªéã§ãç¡«é žã
ãã¿ãã³ã該第äºã®æžæ¿æ¶²ã«æ·»å ãïŒäžã€ (e) ã€ãã§ãå ç«çµåããŠããªã第äºã®èµ€è¡çã
é€å»ããããã«æŽæµãããããŠèµ€è¡çã®è©²ç¬¬äž
ã®å±€ã«çµåããæäœã«å¯Ÿãã該第äºã®èµ€è¡çã®
å ç«ä»çã®çšåºŠã枬å®ãã 段éããæãããšãç¹åŸŽãšããåºäœåºè³ªäžã«ãã
ã现èåãããã¯é©åæ§åææ¹æ³ã ïŒïŒ éä»ç现èåã³æãŸãããªãè©Šè¬ãé€å»ã
ãããã«ã段é(a)ãš(b)ã®éåã³æ®µé(b)ãš(c)ã®é
ã§ã該第äžã®åäžå±€ãæŽæµããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 段é(b)ã«ã€ã¥ããŠèµ€è¡çã®è©²ç¬¬äžã®åäžå±€
ãèžçæ°Žã§äœåŒµçã«åŽ©å£ãããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 段é(b)ã§çšãã該æäœå«æ溶液ããPH7.0
ã«ãããŠ1.9ïŒ ã°ãªã·ã³æº¶æ¶²ã§å°ãªããšãïŒïŒïŒ
ã«åžéããæäœã®è¡æž ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
ïŒé èšèŒã®æ¹æ³ã ïŒïŒ 段é(e)ã«ãããåºè³ªãPHïŒã«ãããŠç匵
NaClåã³ãã¹ããšãŒãç·©è¡å€ããæ¬è³ªçã«ãªã
ç·©è¡æº¶æ¶²ã§æŽæµãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èš
èŒã®æ¹æ³ã ïŒïŒ (a) ãã®äžã«æœãããè¡šé¢å±€ã®æž¬å®ã蚱容
ããããšãŒã¹ãæããå äŒå°æ§åºäœæ¯æèïŒå
ã³ (b) 該ããšãŒã¹ã«å¯ŸããŠéå¯éçã«ä»çããèµ€è¡
ç现èã®åäžå±€ã該赀è¡ç现èã¯è©²çŽ°èã«éæ
æ§ã賊äžããããã«åŽ©å£ãããŠããã該现èã¯
åæãã¹ãæåç決å®èŠçŽ ãæ æããŠããïŒ ããæ¬è³ªçã«æãèµ€è¡ç现èåãããã¯é©åæ§å
æçšåºè³ªã ïŒïŒ 該赀è¡ç现èã®åäžå±€äžã«ãåæãã¹ãæ
åç決å®èŠçŽ ã«ããå ç«åžçãããæäœãæŽã«æ
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®åºè³ªã ïŒïŒ (a) ãã®äžã«æœãããè¡šé¢å±€ã®æž¬å®ã蚱容
ããã®ã«é©åããããããããšãŒã¹ãæããå
äŒå°æ§åºäœæ¯æäœïŒ (b) åºè³ªã«å¯ŸããŠçŽ°èãçµåããã®ã«æå¹ãªåå¿
æ§ã®ååŠåºããã®äžã«æã€è©²ããšãŒã¹ã«æœãã
ãå±€ïŒåã³ (c) 該局(b)ã«ãã€ãŠäžèšããšãŒã¹ã«ä»çããèµ€è¡
ç现èã®åäžå±€ã該赀è¡ç现èã¯è©²çŽ°èã«éæ
æ§ã賊äžããããã«åŽ©å£ãããŠããã該现èã¯
åæãã¹ãæåç決å®èŠçŽ ãæ æããŠããïŒ ããæ¬è³ªçã«æãèµ€è¡ç现èåãããã¯é©åæ§å
æçšåºè³ªã ïŒïŒ 該赀è¡ç现èã®åäžå±€äžã«åæãã¹ãæå
ç決å®èŠçŽ ã«ããå ç«åžçãããæäœãæŽã«æã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®åºè³ªã ïŒïŒ (a) ãã®äžã®è¡šé¢å±€ã®æž¬å®ã蚱容ããã®ã«
é©åããããããããšãŒã¹ãæããããªã¹ãã¬
ã³ã®å äŒå°æ§åºäœæ¯æäœïŒ (b) 該ããªã¹ãã¬ã³åºè³ªã®äžèšããšãŒã¹ã«çµåã
ããã€ããªããŒã²ã³ã®å±€ïŒåã³ (c) 該ãã€ããªããŒã²ã³ã«çµåããããªãªãžã³ã®
å±€ã該ããªãªãžã³å±€ã¯åæãã¹ã现èã®åäžå±€
ãéå¯éçã«çµåãåŸãå±€ã§ããïŒ ããæ¬è³ªçã«æã现èåãããã¯é©åæ§åæçšåº
質ã ïŒïŒ 該ããªãªãžã³å±€ã«éå¯éçã«çµåãã现è
ã®åäžå±€ãæãã該现èã®åäžå±€ã¯åæãã¹ãæ
åç決å®èŠçŽ ãæ æããŠããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
ïŒé èšèŒã®åºè³ªã ïŒïŒ (a) åºäœåºè³ªã«å¯ŸããŠéå¯éçã«çµåãã
现èã該现èã¯ãã®äžã«æåãæãããããã
ã¯æ æããŠãããã®ç¬¬äžã®åäžå±€ã圢æãã
ãïŒ (b) 該局(a)ãã該现èã®ç¬¬äžã®å±€ã«å ç«åžçã«ã
ãçµåããæäœã®å±€ã圢æãåŸãæäœãå«æã
ã溶液ãšã該溶液ã®æäœã該第äžã®å±€ã®çŽ°èã®
æåãšåå¿æ§ã§ããçšåºŠãŸã§æ¥è§ŠãããïŒ (c) ç¶ãã®ã¡ãå ç«åžçãããæäœã®ååšäžã«ã
該局(a)ã®çŽ°èã厩å£ããã®ã«æå¹ãªæº¶èçŽ çæ
æ§ïŒlyticïŒè£äœãå«æãã第äºã®æº¶æ¶²ãäœçš
ãããããŠçããå ç«åŽ©å£ã®çšåºŠãèŠå¯ããã
ãšã«ãã€ãŠã該æäœã®å ç«åžçã®çšåºŠã枬å®ã
ã 段éããæãããšãç¹åŸŽãšããåºäœåºè³ªäžã«ãã
ã现èåãããã¯é©åæ§åææ¹æ³ã ïŒïŒ 該第äžã®å±€ã®çŽ°èã第äžã®å人ã®çŽ°èã§ã
ã€ãŠãäžã€è©²æäœãå«æãã溶液ã第äºã®å人ã
ãåŸãããè¡æž ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èš
èŒã®æ¹æ³ã ïŒïŒ 該现èå±€(a)ãã被èŠãããã¹ã該åºäœåºè³ª
ã«çŽ°èã®æžæ¿æ¶²ãäœçšãããããšã«ãã圢æã
ãã該åºè³ªã®è¡šé¢äžã«ã¯è©²çŽ°èãäžèšåºè³ªã«é£çµ
ããã®ã«æå¹ãªåå¿æ§ã®ååŠåºãååšããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該第äžã®å±€(a)ã®çŽ°èãèµ€è¡çã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該åå¿æ§ã®ååŠåºããããªã¹ãã¬ã³åºäœåº
質ããã€ããªããŒã²ã³æº¶æ¶²åã³ããªãªãžã³æº¶æ¶²
ã§ã該åºè³ªã®è¡šé¢ã«è©²åå¿æ§ã®ååŠåºã圢æãã
ã®ã«æå¹ãªæ¡ä»¶äžã«ãé 次åŠçããããšã«ãã圢
æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ 該现èã®åäžå±€(a)ãã被èŠãããã¹ã該åº
äœåºè³ªã«è©²çŽ°èã®æžæ¿æ¶²ãäœçšãããããšã«ãã
圢æããã該åºè³ªã®è¡šé¢äžã«ã¯è©²çŽ°èãäžèšåºè³ª
ã«é£çµããã®ã«æå¹ãªåå¿æ§ã®ååŠåºãååšãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60480475A | 1975-08-14 | 1975-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5238789A JPS5238789A (en) | 1977-03-25 |
JPS6244221B2 true JPS6244221B2 (ja) | 1987-09-18 |
Family
ID=24421121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9615776A Granted JPS5238789A (en) | 1975-08-14 | 1976-08-13 | Method of identifying hematocyte type and adaptability |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5238789A (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4948820A (ja) * | 1972-06-26 | 1974-05-11 | ||
US3843777A (en) * | 1969-08-07 | 1974-10-22 | Baxter Laboratories Inc | Hemolytic assay system |
JPS5022086A (ja) * | 1973-05-31 | 1975-03-08 | ||
JPS5076226A (ja) * | 1973-07-30 | 1975-06-21 | ||
JPS50160423A (ja) * | 1974-05-29 | 1975-12-25 |
-
1976
- 1976-08-13 JP JP9615776A patent/JPS5238789A/ja active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3843777A (en) * | 1969-08-07 | 1974-10-22 | Baxter Laboratories Inc | Hemolytic assay system |
JPS4948820A (ja) * | 1972-06-26 | 1974-05-11 | ||
JPS5022086A (ja) * | 1973-05-31 | 1975-03-08 | ||
JPS5076226A (ja) * | 1973-07-30 | 1975-06-21 | ||
JPS50160423A (ja) * | 1974-05-29 | 1975-12-25 |
Also Published As
Publication number | Publication date |
---|---|
JPS5238789A (en) | 1977-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4275053A (en) | Blood cell typing and compatibility test procedure | |
TW297094B (ja) | ||
JP5181058B2 (ja) | ããïœïœïœïŒïœïœïŒïœïœè¡æ¶²åãè¿ éã«å€å®ããæ¹æ³åã³ããã | |
JP3330604B2 (ja) | åºçžå ç«åŠçæ€å®æ³ | |
JP3022930B2 (ja) | 移æ€çå容ã®æ¹è¯ãããè©äŸ¡ | |
EA017380B1 (ru) | ÐпÑеЎелеМОе аМÑОгеМПв, ÑаÑпПлПжеММÑÑ ÐœÐ° ÑÑОÑÑПÑОÑÐ°Ñ , О аМÑОÑÑОÑÑПÑОÑаÑÐœÑÑ Ð°ÐœÑОÑел | |
JPH03502241A (ja) | ããè¡æž ã«ãããïœïœïœæåãæ€åºããé µçŽ å ç«æ€å®æ³ | |
US4328183A (en) | Blood cell typing and compatibility test procedure | |
DK174032B1 (da) | SÊt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler | |
AU619019B2 (en) | An article for performing immunological assays utilizing organic dyes and methods for producing and utilizing same | |
JP2824794B2 (ja) | åºçžæ³ã«ããèµ€è¡çæäœãæ¢çŽ¢ããåå®ããæ¹æ³ | |
CN1444044A (zh) | ä»¥é ¶èå ç«æµå®äžºåºç¡çhlaè¡¥äœäŸèµæ§ç»èæ¯æ§æäœæ£æµæ¹æ³åè¯åç | |
JP2553852B2 (ja) | ãµã³ãã«äžã®çç©åŠçç©è³ªã®å ç«åŠç枬å®æ³ | |
CA1089359A (en) | Blood cell typing and compatibility test by solid phase immunoadsorbtion | |
JPS60177265A (ja) | æäœã®å ç«ã°ãããªã³ã®ã¯ã©ã¹å¥æ€åºæ³ | |
JPS6244221B2 (ja) | ||
GB2217335A (en) | Compositions for isolation and immobilisation of C-reactive protein in body liquids | |
Penney et al. | Polycarbonate membranes: a novel surface for solid-phase determinations with utility in field format serological assays | |
EP1497652B1 (en) | Method, system and kit for detecting an analyte in a sample | |
WO2017130829A1 (ja) | ãã€ã¯ãã¢ã¬ã€ããã€ã¯ãã¢ã¬ã€ã®è£œé æ¹æ³ãæ€æ»æ¹æ³ãåã³æ€æ»ããã | |
JPH0961429A (ja) | æã¢ã«ããªãŠã€ã«ã¹å±ãŠã€ã«ã¹æäœã®ç°¡æ蚺æè©Šè¬ | |
JPH09229938A (ja) | ææ¢ æ¯ãã¬ãããŒãæäœã®å ç«åææ¹æ³åã³å ç«åæè£ çœ® | |
KR930000951A (ko) | ì§ëš ë°©ë² | |
JPH06148188A (ja) | å ç«åŠçåæ€æ»æ¹æ³ | |
JPH07501396A (ja) | ïœïœïŒããçœè¡çæåïŒã®ã¿ã€ãåãæ¹æ³ |